{
  "SOBR": {
    "Symbol": "SOBR",
    "AssetType": "Common Stock",
    "Name": "Sobr Safe Inc",
    "Description": "SOBR Safe, Inc. develops non-invasive identity verification and alcohol detection systems. The company is headquartered in Greenwood Village, Colorado.",
    "CIK": "1425627",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "PERIODICALS: PUBLISHING OR PUBLISHING & PRINTING",
    "Address": "885 ARAPAHOE ROAD, BOULDER, CO, US",
    "OfficialSite": "https://sobrsafe.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "1032600",
    "EBITDA": "-7435655",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.61",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-51.46",
    "RevenuePerShareTTM": "0.858",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-40.06",
    "ReturnOnAssetsTTM": "-0.891",
    "ReturnOnEquityTTM": "-2.917",
    "RevenueTTM": "183860",
    "GrossProfitTTM": "73820",
    "DilutedEPSTTM": "-51.46",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.272",
    "AnalystTargetPrice": "4.25",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "5.62",
    "PriceToBookRatio": "0.495",
    "EVToRevenue": "6.5",
    "EVToEBITDA": "-3.721",
    "Beta": "-0.097",
    "52WeekHigh": "81.4",
    "52WeekLow": "0.79",
    "50DayMovingAverage": "1.315",
    "200DayMovingAverage": "11.3",
    "SharesOutstanding": "921950",
    "DividendDate": "2020-06-08",
    "ExDividendDate": "None"
  },
  "TLRY": {
    "Symbol": "TLRY",
    "AssetType": "Common Stock",
    "Name": "Tilray Inc",
    "Description": "Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.",
    "CIK": "1731348",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "MEDICINAL CHEMICALS & BOTANICAL PRODUCTS",
    "Address": "1100 MAUGHAN ROAD, NANAIMO, BC, CA",
    "OfficialSite": "https://www.tilray.com",
    "FiscalYearEnd": "May",
    "LatestQuarter": "2024-11-30",
    "MarketCapitalization": "888675000",
    "EBITDA": "31318000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "3.752",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.3",
    "RevenuePerShareTTM": "1.029",
    "ProfitMargin": "-0.3",
    "OperatingMarginTTM": "-0.153",
    "ReturnOnAssetsTTM": "-0.0145",
    "ReturnOnEquityTTM": "-0.0702",
    "RevenueTTM": "829216000",
    "GrossProfitTTM": "256646000",
    "DilutedEPSTTM": "-0.3",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.089",
    "AnalystTargetPrice": "1.824",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "10",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "1000",
    "PriceToSalesRatioTTM": "1.072",
    "PriceToBookRatio": "0.254",
    "EVToRevenue": "1.211",
    "EVToEBITDA": "-4.841",
    "Beta": "1.986",
    "52WeekHigh": "2.97",
    "52WeekLow": "0.825",
    "50DayMovingAverage": "1.168",
    "200DayMovingAverage": "1.582",
    "SharesOutstanding": "933973000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "RTC": {
    "Symbol": "RTC",
    "AssetType": "Common Stock",
    "Name": "Baijiayun Group Ltd",
    "Description": "Baijiayun Group Ltd engages in the provision of video-centric technology solutions. The company is headquartered in Beijing, China.",
    "CIK": "1381074",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "MANUFACTURING",
    "Industry": "UNSUPPORTED PLASTICS FILM & SHEET",
    "Address": "NO. 387 DONGMING ROAD, WEIFANG, SHANDONG, CHINA",
    "OfficialSite": "https://www.baijiayun.com",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2023-12-31",
    "MarketCapitalization": "13704900",
    "EBITDA": "-48347028",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "1.227",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-4.25",
    "RevenuePerShareTTM": "3.105",
    "ProfitMargin": "-1.369",
    "OperatingMarginTTM": "-1.002",
    "ReturnOnAssetsTTM": "-0.308",
    "ReturnOnEquityTTM": "-1.464",
    "RevenueTTM": "59795000",
    "GrossProfitTTM": "12992300",
    "DilutedEPSTTM": "-4.25",
    "QuarterlyEarningsGrowthYOY": "-0.308",
    "QuarterlyRevenueGrowthYOY": "-0.253",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.229",
    "PriceToBookRatio": "0.542",
    "EVToRevenue": "0.237",
    "EVToEBITDA": "7.42",
    "Beta": "-0.278",
    "52WeekHigh": "9.69",
    "52WeekLow": "0.45",
    "50DayMovingAverage": "2.353",
    "200DayMovingAverage": "5.81",
    "SharesOutstanding": "19659000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "GRAB": {
    "Symbol": "GRAB",
    "AssetType": "Common Stock",
    "Name": "Grab Holdings Ltd",
    "Description": "None",
    "CIK": "1855612",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-BUSINESS SERVICES, NEC",
    "Address": "3 MEDIA CLOSE, #01-03/06, SINGAPORE, SINGAPORE",
    "OfficialSite": "https://www.grab.com/sg",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "19918500000",
    "EBITDA": "-7000000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "1.574",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.03",
    "RevenuePerShareTTM": "0.7",
    "ProfitMargin": "-0.0375",
    "OperatingMarginTTM": "0.0118",
    "ReturnOnAssetsTTM": "-0.0106",
    "ReturnOnEquityTTM": "-0.0247",
    "RevenueTTM": "2797000000",
    "GrossProfitTTM": "1174000000",
    "DilutedEPSTTM": "-0.03",
    "QuarterlyEarningsGrowthYOY": "-0.252",
    "QuarterlyRevenueGrowthYOY": "0.17",
    "AnalystTargetPrice": "5.76",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "18",
    "AnalystRatingHold": "5",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "88.5",
    "PriceToSalesRatioTTM": "7.12",
    "PriceToBookRatio": "3.113",
    "EVToRevenue": "5.24",
    "EVToEBITDA": "92.74",
    "Beta": "0.902",
    "52WeekHigh": "5.72",
    "52WeekLow": "2.98",
    "50DayMovingAverage": "4.82",
    "200DayMovingAverage": "4.035",
    "SharesOutstanding": "3950000000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "NKGN": {
    "Symbol": "NKGN",
    "AssetType": "Common Stock",
    "Name": "NKGen Biotech, Inc. Common Stock",
    "Description": "NKGen Biotech, Inc. is a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. The company is headquartered in Santa Ana, California.",
    "CIK": "1845459",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "BLANK CHECKS",
    "Address": "1790 HUGHES LANDING BOULEVARD, SUITE 400, THE WOODLANDS, TX, US",
    "OfficialSite": "https://nkgenbiotech.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "25597700",
    "EBITDA": "-30226000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-2.705",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-3.42",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-1.069",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "59000",
    "DilutedEPSTTM": "-3.42",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1215.21",
    "PriceToBookRatio": "-",
    "EVToRevenue": "964.78",
    "EVToEBITDA": "-1.129",
    "Beta": "0.475",
    "52WeekHigh": "3.1",
    "52WeekLow": "0.203",
    "50DayMovingAverage": "0.546",
    "200DayMovingAverage": "0.765",
    "SharesOutstanding": "44947600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "RETO": {
    "Symbol": "RETO",
    "AssetType": "Common Stock",
    "Name": "ReTo Eco-Solutions Inc",
    "Description": "ReTo Eco-Solutions, Inc. manufactures and distributes building materials primarily in China. The company is headquartered in Beijing, the People's Republic of China.",
    "CIK": "1687277",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "ABRASIVE, ASBESTOS & MISC NONMETALLIC MINERAL PRODS",
    "Address": "C/O BEIJING REIT TECH DEVELOP CO. LTD., X-702, 60 ANLI ROAD, CHAOYANG DISTRICT, BEIJING, CHINA",
    "OfficialSite": "https://www.retoeco.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "15243400",
    "EBITDA": "-4335168",
    "PERatio": "0.797",
    "PEGRatio": "None",
    "BookValue": "3.481",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.96",
    "RevenuePerShareTTM": "2.016",
    "ProfitMargin": "-1.328",
    "OperatingMarginTTM": "-0.584",
    "ReturnOnAssetsTTM": "-0.116",
    "ReturnOnEquityTTM": "-0.794",
    "RevenueTTM": "3841100",
    "GrossProfitTTM": "683960",
    "DilutedEPSTTM": "0.96",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.49",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "0.797",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "3.969",
    "PriceToBookRatio": "1.084",
    "EVToRevenue": "5.73",
    "EVToEBITDA": "-1.277",
    "Beta": "1.249",
    "52WeekHigh": "3.836",
    "52WeekLow": "0.325",
    "50DayMovingAverage": "0.769",
    "200DayMovingAverage": "1.261",
    "SharesOutstanding": "19352600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "AEP": {
    "Symbol": "AEP",
    "AssetType": "Common Stock",
    "Name": "American Electric Power Co Inc",
    "Description": "American Electric Power (AEP) is a major investor-owned electric utility in the United States, delivering electricity to more than five million customers in 11 states.",
    "CIK": "4904",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "ENERGY & TRANSPORTATION",
    "Industry": "ELECTRIC SERVICES",
    "Address": "1 RIVERSIDE PLAZA, COLUMBUS, OH, US",
    "OfficialSite": "https://www.aep.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "56163115000",
    "EBITDA": "7823600000",
    "PERatio": "18.88",
    "PEGRatio": "1.591",
    "BookValue": "50.56",
    "DividendPerShare": "3.57",
    "DividendYield": "0.0353",
    "EPS": "5.58",
    "RevenuePerShareTTM": "37.2",
    "ProfitMargin": "0.15",
    "OperatingMarginTTM": "0.263",
    "ReturnOnAssetsTTM": "0.0286",
    "ReturnOnEquityTTM": "0.114",
    "RevenueTTM": "19721300000",
    "GrossProfitTTM": "9332300000",
    "DilutedEPSTTM": "5.58",
    "QuarterlyEarningsGrowthYOY": "0.97",
    "QuarterlyRevenueGrowthYOY": "0.026",
    "AnalystTargetPrice": "102.13",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "14",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "18.88",
    "ForwardPE": "17.83",
    "PriceToSalesRatioTTM": "2.848",
    "PriceToBookRatio": "2.084",
    "EVToRevenue": "5.15",
    "EVToEBITDA": "12.53",
    "Beta": "0.565",
    "52WeekHigh": "105.73",
    "52WeekLow": "76.22",
    "50DayMovingAverage": "96.39",
    "200DayMovingAverage": "95.86",
    "SharesOutstanding": "533211000",
    "DividendDate": "2025-03-10",
    "ExDividendDate": "2025-02-10"
  },
  "NAAS": {
    "Symbol": "NAAS",
    "AssetType": "Common Stock",
    "Name": "Naas Technology Inc ADR",
    "Description": "None",
    "CIK": "1712178",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TRADE & SERVICES",
    "Industry": "RETAIL-RETAIL STORES, NEC",
    "Address": "NEWLINK CENTER, AREA G, BUILDING 7, HUITONG TIMES SQUARE, CHAOYANG DISTRICT, CHINA",
    "OfficialSite": "https://www.enaas.com/en/",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "22467100",
    "EBITDA": "-685339520",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-16.33",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-9.75",
    "RevenuePerShareTTM": "23.8",
    "ProfitMargin": "-2.855",
    "OperatingMarginTTM": "-1.129",
    "ReturnOnAssetsTTM": "-0.283",
    "ReturnOnEquityTTM": "-19.39",
    "RevenueTTM": "303436000",
    "GrossProfitTTM": "97968000",
    "DilutedEPSTTM": "-9.75",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.551",
    "AnalystTargetPrice": "96",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.074",
    "PriceToBookRatio": "12.36",
    "EVToRevenue": "2.962",
    "EVToEBITDA": "-0.399",
    "Beta": "1.518",
    "52WeekHigh": "34.2",
    "52WeekLow": "1.3",
    "50DayMovingAverage": "1.768",
    "200DayMovingAverage": "4.224",
    "SharesOutstanding": "6645700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "HOLO": {
    "Symbol": "HOLO",
    "AssetType": "Common Stock",
    "Name": "MicroCloud Hologram Inc.",
    "Description": "None",
    "CIK": "1841209",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.",
    "Address": "100 PARK AVENUE, NEW YORK, NY, US",
    "OfficialSite": "https://www.mcholo.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "21571400",
    "EBITDA": "-176474096",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "130.92",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-23.71",
    "RevenuePerShareTTM": "297.87",
    "ProfitMargin": "-0.74",
    "OperatingMarginTTM": "-1.043",
    "ReturnOnAssetsTTM": "-0.217",
    "ReturnOnEquityTTM": "-0.391",
    "RevenueTTM": "234301000",
    "GrossProfitTTM": "47724000",
    "DilutedEPSTTM": "-23.71",
    "QuarterlyEarningsGrowthYOY": "0.299",
    "QuarterlyRevenueGrowthYOY": "0.282",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.0921",
    "PriceToBookRatio": "0.219",
    "EVToRevenue": "1.091",
    "EVToEBITDA": "0.844",
    "Beta": "3.663",
    "52WeekHigh": "171.6",
    "52WeekLow": "0.918",
    "50DayMovingAverage": "1.889",
    "200DayMovingAverage": "8.73",
    "SharesOutstanding": "20544200",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "NVO": {
    "Symbol": "NVO",
    "AssetType": "Common Stock",
    "Name": "Novo Nordisk A/S",
    "Description": "Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in Bagsvaerd, Denmark.",
    "CIK": "353278",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "NOVO ALLE DK 2880, BAGSVAERD DENMARK, DK",
    "OfficialSite": "https://www.novonordisk.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "369140662000",
    "EBITDA": "146668995000",
    "PERatio": "27.87",
    "PEGRatio": "1.275",
    "BookValue": "32.31",
    "DividendPerShare": "11.4",
    "DividendYield": "0.0183",
    "EPS": "3.16",
    "RevenuePerShareTTM": "65.2",
    "ProfitMargin": "0.348",
    "OperatingMarginTTM": "0.497",
    "ReturnOnAssetsTTM": "0.224",
    "ReturnOnEquityTTM": "0.808",
    "RevenueTTM": "290402992000",
    "GrossProfitTTM": "246842999000",
    "DilutedEPSTTM": "3.16",
    "QuarterlyEarningsGrowthYOY": "0.292",
    "QuarterlyRevenueGrowthYOY": "0.301",
    "AnalystTargetPrice": "110.7",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "3",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "27.87",
    "ForwardPE": "23.09",
    "PriceToSalesRatioTTM": "1.271",
    "PriceToBookRatio": "19.51",
    "EVToRevenue": "9.89",
    "EVToEBITDA": "20.91",
    "Beta": "0.192",
    "52WeekHigh": "147.6",
    "52WeekLow": "77.82",
    "50DayMovingAverage": "88.64",
    "200DayMovingAverage": "117.58",
    "SharesOutstanding": "3364180000",
    "DividendDate": "2025-04-08",
    "ExDividendDate": "2025-03-31"
  },
  "MLGO": {
    "Symbol": "MLGO",
    "AssetType": "Common Stock",
    "Name": "MicroAlgo Inc.",
    "Description": "MicroAlgo Inc. develops and delivers central processing algorithm solutions to customers in internet advertisement, gaming, and intelligent chip industries in the People's Republic of China and internationally. The company is headquartered in Shenzhen, the People's Republic of China.",
    "CIK": "1800392",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING SERVICES",
    "Address": "340 MADISON AVENUE,19TH FLOOR, NEW YORK, NY, US",
    "OfficialSite": "https://www.microalgor.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "63427000",
    "EBITDA": "-107966232",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "623.82",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-140.6",
    "RevenuePerShareTTM": "1594.35",
    "ProfitMargin": "-0.354",
    "OperatingMarginTTM": "0.0093",
    "ReturnOnAssetsTTM": "-0.106",
    "ReturnOnEquityTTM": "-0.41",
    "RevenueTTM": "606816000",
    "GrossProfitTTM": "180924000",
    "DilutedEPSTTM": "-140.6",
    "QuarterlyEarningsGrowthYOY": "-0.897",
    "QuarterlyRevenueGrowthYOY": "0.081",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.104",
    "PriceToBookRatio": "0.835",
    "EVToRevenue": "0.235",
    "EVToEBITDA": "2.673",
    "Beta": "2.628",
    "52WeekHigh": "509.6",
    "52WeekLow": "1.11",
    "50DayMovingAverage": "2.088",
    "200DayMovingAverage": "32.03",
    "SharesOutstanding": "9972800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BREA": {
    "Symbol": "BREA",
    "AssetType": "Common Stock",
    "Name": "Brera Holdings PLC Class B Ordinary Shares",
    "Description": "Brera Holdings PLC develops, manages, and operates football clubs. The company is headquartered in Dublin, Ireland.",
    "CIK": "1939965",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-AMUSEMENT & RECREATION SERVICES",
    "Address": "IFSC, 25-28 NORTH WALL QUAY, DUBLIN 1, DUBLIN, IRELAND",
    "OfficialSite": "https://www.breraholdings.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "11969100",
    "EBITDA": "-6412997",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.039",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.5",
    "RevenuePerShareTTM": "0.224",
    "ProfitMargin": "-2.178",
    "OperatingMarginTTM": "-1.964",
    "ReturnOnAssetsTTM": "-0.717",
    "ReturnOnEquityTTM": "-2.498",
    "RevenueTTM": "2680500",
    "GrossProfitTTM": "2444500",
    "DilutedEPSTTM": "-0.5",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "19.4",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "4.465",
    "PriceToBookRatio": "15.39",
    "EVToRevenue": "3.083",
    "EVToEBITDA": "-4.506",
    "Beta": "0.592",
    "52WeekHigh": "2.44",
    "52WeekLow": "0.5",
    "50DayMovingAverage": "0.723",
    "200DayMovingAverage": "0.785",
    "SharesOutstanding": "6625000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "CDT": {
    "Symbol": "CDT",
    "AssetType": "Common Stock",
    "Name": "Conduit Pharmaceuticals Inc.",
    "Description": "None",
    "CIK": "1896212",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "4995 MURPHY CANYON ROAD, SUITE 300, SAN DIEGO, CA, UNITED STATES",
    "OfficialSite": "https://www.conduitpharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "5648700",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-9.5",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-23",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-1.088",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-23",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-55.41",
    "Beta": "2.159",
    "52WeekHigh": "392",
    "52WeekLow": "1.09",
    "50DayMovingAverage": "4.681",
    "200DayMovingAverage": "50.73",
    "SharesOutstanding": "4707200",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MFI": {
    "Symbol": "MFI",
    "AssetType": "Common Stock",
    "Name": "mF International Limited Ordinary Shares",
    "Description": "None",
    "CIK": "1940941",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING SERVICES",
    "Address": "UNIT 1801, FORTIS TOWER, 77-79 GLOUCESTER ROAD, WAN CHAI, HK",
    "OfficialSite": "https://www.m-finance.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "8348600",
    "EBITDA": "-2127358",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "3.817",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.02",
    "RevenuePerShareTTM": "2.546",
    "ProfitMargin": "-0.0376",
    "OperatingMarginTTM": "-0.507",
    "ReturnOnAssetsTTM": "-0.0265",
    "ReturnOnEquityTTM": "-0.0375",
    "RevenueTTM": "30278500",
    "GrossProfitTTM": "15994700",
    "DilutedEPSTTM": "-0.02",
    "QuarterlyEarningsGrowthYOY": "1.179",
    "QuarterlyRevenueGrowthYOY": "-0.119",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.276",
    "PriceToBookRatio": "1.284",
    "EVToRevenue": "1.466",
    "EVToEBITDA": "9.33",
    "Beta": "None",
    "52WeekHigh": "14.49",
    "52WeekLow": "0.506",
    "50DayMovingAverage": "0.737",
    "200DayMovingAverage": "0.829",
    "SharesOutstanding": "13251700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SOPA": {
    "Symbol": "SOPA",
    "AssetType": "Common Stock",
    "Name": "Society Pass Inc",
    "Description": "Society Pass Incorporated is dedicated to the acquisition and operation of e-commerce platforms for consumers and merchants in Southeast Asia. The company is headquartered in Carson City, Nevada.",
    "CIK": "1817511",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-BUSINESS SERVICES, NEC",
    "Address": "30 GONDOLIERS BLUFF, NEWPORT COAST, CA, US",
    "OfficialSite": "https://thesocietypass.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "5869600",
    "EBITDA": "-10511758",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.24",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-5",
    "RevenuePerShareTTM": "2.671",
    "ProfitMargin": "-1.711",
    "OperatingMarginTTM": "-0.701",
    "ReturnOnAssetsTTM": "-0.37",
    "ReturnOnEquityTTM": "-2.218",
    "RevenueTTM": "6906200",
    "GrossProfitTTM": "1966600",
    "DilutedEPSTTM": "-5",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.261",
    "AnalystTargetPrice": "16",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.85",
    "PriceToBookRatio": "7.4",
    "EVToRevenue": "0.507",
    "EVToEBITDA": "-0.0879",
    "Beta": "1.342",
    "52WeekHigh": "6.75",
    "52WeekLow": "0.727",
    "50DayMovingAverage": "1.511",
    "200DayMovingAverage": "1.299",
    "SharesOutstanding": "3645700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MBRX": {
    "Symbol": "MBRX",
    "AssetType": "Common Stock",
    "Name": "Moleculin Biotech Inc",
    "Description": "Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of cancer drug candidates for the treatment of highly resistant viruses and tumors in the United States. The company is headquartered in Houston, Texas.",
    "CIK": "1659617",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "5300 MEMORIAL DRIVE, SUITE 950, HOUSTON, TX, US",
    "OfficialSite": "https://moleculin.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "4446800",
    "EBITDA": "-28787000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "2.491",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-12.04",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.575",
    "ReturnOnEquityTTM": "-1.415",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-12.04",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "28",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "0.711",
    "EVToRevenue": "-",
    "EVToEBITDA": "0.523",
    "Beta": "1.935",
    "52WeekHigh": "10.35",
    "52WeekLow": "0.398",
    "50DayMovingAverage": "1.667",
    "200DayMovingAverage": "2.802",
    "SharesOutstanding": "4155900",
    "DividendDate": "2021-02-01",
    "ExDividendDate": "None"
  },
  "WAFU": {
    "Symbol": "WAFU",
    "AssetType": "Common Stock",
    "Name": "Wah Fu Education Group Ltd",
    "Description": "Wah Fu Education Group Limited, provides online exam preparation services and related technology solutions in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.",
    "CIK": "1716770",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-EDUCATIONAL SERVICES",
    "Address": "RM 505 BLDG NO. 40, NO. 1 DISHENG N ST, ECONOMIC & TECHNOLOGICAL DEVELOP. ZONE, BEIJING, CHINA",
    "OfficialSite": "https://www.edu-edu.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "8071800",
    "EBITDA": "-116491",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "2.528",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.01",
    "RevenuePerShareTTM": "1.631",
    "ProfitMargin": "-0.0077",
    "OperatingMarginTTM": "-0.144",
    "ReturnOnAssetsTTM": "-0.0089",
    "ReturnOnEquityTTM": "-0.0299",
    "RevenueTTM": "7223200",
    "GrossProfitTTM": "3023500",
    "DilutedEPSTTM": "-0.01",
    "QuarterlyEarningsGrowthYOY": "-0.737",
    "QuarterlyRevenueGrowthYOY": "-0.318",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.117",
    "PriceToBookRatio": "0.724",
    "EVToRevenue": "0.063",
    "EVToEBITDA": "-1.558",
    "Beta": "0.96",
    "52WeekHigh": "2.63",
    "52WeekLow": "1.46",
    "50DayMovingAverage": "1.705",
    "200DayMovingAverage": "1.808",
    "SharesOutstanding": "4410600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SLXN": {
    "Symbol": "SLXN",
    "AssetType": "Common Stock",
    "Name": "Biomotion Sciences Ordinary Shares",
    "Description": "None",
    "CIK": "2022416",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "12 ABBA HILLEL ROAD, RAMAT-GAN, IL",
    "OfficialSite": "https://silexion.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "9866100",
    "EBITDA": "-1355000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "4.669",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.66",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.621",
    "ReturnOnEquityTTM": "-1.167",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-0.66",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "13.56",
    "52WeekLow": "0.207",
    "50DayMovingAverage": "7.62",
    "200DayMovingAverage": "10.27",
    "SharesOutstanding": "9768400",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "PITA": {
    "Symbol": "PITA",
    "AssetType": "Common Stock",
    "Name": "Heramba Electric plc Ordinary Shares",
    "Description": "None",
    "CIK": "None",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "GENERAL",
    "Address": "NONE",
    "OfficialSite": "None",
    "FiscalYearEnd": "None",
    "LatestQuarter": "None",
    "MarketCapitalization": "None",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "None",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "None",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "0",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "15",
    "52WeekLow": "0.343",
    "50DayMovingAverage": "0",
    "200DayMovingAverage": "0",
    "SharesOutstanding": "0",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "GTBP": {
    "Symbol": "GTBP",
    "AssetType": "Common Stock",
    "Name": "GT Biopharma Inc",
    "Description": "GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its patented immune-enhancer cell fusion protein Tri-specific Killer Engager (TriKE) technology platform. The company is headquartered in Beverly Hills, California.",
    "CIK": "109657",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1825 K STREET, SUITE 510, WASHINGTON, D.C., DC, US",
    "OfficialSite": "https://www.gtbiopharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "6233800",
    "EBITDA": "-6760000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "5.41",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-7.39",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.606",
    "ReturnOnEquityTTM": "-1.315",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-7.39",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "11",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "2.164",
    "EVToRevenue": "-",
    "EVToEBITDA": "-0.0876",
    "Beta": "0.57",
    "52WeekHigh": "10.66",
    "52WeekLow": "1.72",
    "50DayMovingAverage": "2.625",
    "200DayMovingAverage": "3.128",
    "SharesOutstanding": "2234300",
    "DividendDate": "2017-08-21",
    "ExDividendDate": "None"
  },
  "ENVB": {
    "Symbol": "ENVB",
    "AssetType": "Common Stock",
    "Name": "Enveric Biosciences Inc",
    "Description": "Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.",
    "CIK": "890821",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "SEMICONDUCTORS & RELATED DEVICES",
    "Address": "2025 GATEWAY PLACE, SUITE 365, SAN JOSE, CA, US",
    "OfficialSite": "https://www.enveric.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "2267900",
    "EBITDA": "-8503116",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.59",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-36.3",
    "RevenuePerShareTTM": "37.68",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.969",
    "ReturnOnEquityTTM": "-3.086",
    "RevenueTTM": "35405100",
    "GrossProfitTTM": "8150700",
    "DilutedEPSTTM": "-36.3",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.073",
    "AnalystTargetPrice": "8.32",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "23.09",
    "PriceToSalesRatioTTM": "0.0831",
    "PriceToBookRatio": "0.669",
    "EVToRevenue": "1.758",
    "EVToEBITDA": "0.289",
    "Beta": "0.191",
    "52WeekHigh": "43.8",
    "52WeekLow": "1.13",
    "50DayMovingAverage": "49.29",
    "200DayMovingAverage": "104.41",
    "SharesOutstanding": "1921900",
    "DividendDate": "2019-11-25",
    "ExDividendDate": "2008-04-23"
  },
  "ONVO": {
    "Symbol": "ONVO",
    "AssetType": "Common Stock",
    "Name": "Organovo Holdings Inc",
    "Description": "Organovo Holdings, Inc., a biotechnology company, is focused on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in Solana Beach, California.",
    "CIK": "1497253",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO, CA, US",
    "OfficialSite": "https://www.organovo.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "22167200",
    "EBITDA": "-12282000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.021",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.84",
    "RevenuePerShareTTM": "0.008",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-144.5",
    "ReturnOnAssetsTTM": "-1.234",
    "ReturnOnEquityTTM": "-3.784",
    "RevenueTTM": "122000",
    "GrossProfitTTM": "-5112000",
    "DilutedEPSTTM": "-0.84",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "3.8",
    "AnalystTargetPrice": "5.4",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "181.7",
    "PriceToBookRatio": "17.69",
    "EVToRevenue": "51.96",
    "EVToEBITDA": "-0.336",
    "Beta": "0.532",
    "52WeekHigh": "1.83",
    "52WeekLow": "0.315",
    "50DayMovingAverage": "0.377",
    "200DayMovingAverage": "0.56",
    "SharesOutstanding": "17454500",
    "DividendDate": "2020-08-19",
    "ExDividendDate": "None"
  },
  "DOMH": {
    "Symbol": "DOMH",
    "AssetType": "Common Stock",
    "Name": "Dominari Holdings Inc.",
    "Description": "None",
    "CIK": "12239",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "PATENT OWNERS & LESSORS",
    "Address": "ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK, NY, US",
    "OfficialSite": "https://www.dominariholdings.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "108040000",
    "EBITDA": "-14179000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.1",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "-3.86",
    "RevenuePerShareTTM": "2.113",
    "ProfitMargin": "-1.802",
    "OperatingMarginTTM": "-0.79",
    "ReturnOnAssetsTTM": "-0.425",
    "ReturnOnEquityTTM": "-0.47",
    "RevenueTTM": "12589000",
    "GrossProfitTTM": "12589000",
    "DilutedEPSTTM": "-3.86",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "3.198",
    "AnalystTargetPrice": "16",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "8.58",
    "PriceToBookRatio": "2.127",
    "EVToRevenue": "6.15",
    "EVToEBITDA": "1.696",
    "Beta": "1.266",
    "52WeekHigh": "13.05",
    "52WeekLow": "0.794",
    "50DayMovingAverage": "3.205",
    "200DayMovingAverage": "2.184",
    "SharesOutstanding": "10913100",
    "DividendDate": "2025-03-03",
    "ExDividendDate": "2025-02-24"
  },
  "JTAI": {
    "Symbol": "JTAI",
    "AssetType": "Common Stock",
    "Name": "Jet.AI Inc.",
    "Description": "Jet. The company is headquartered in Las Vegas, Nevada.",
    "CIK": "1861622",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "BLANK CHECKS",
    "Address": "SUITE 201, 42 EDWARD STREET, GEORGE TOWN, GRAND CAYMAN, KY",
    "OfficialSite": "https://jet.ai",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "11336300",
    "EBITDA": "-12325496",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-33.78",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-191.17",
    "RevenuePerShareTTM": "234.42",
    "ProfitMargin": "-0.831",
    "OperatingMarginTTM": "-0.736",
    "ReturnOnAssetsTTM": "-1.898",
    "ReturnOnEquityTTM": "-31.99",
    "RevenueTTM": "15028900",
    "GrossProfitTTM": "-628371",
    "DilutedEPSTTM": "-191.17",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.163",
    "AnalystTargetPrice": "20",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.754",
    "PriceToBookRatio": "-",
    "EVToRevenue": "0.896",
    "EVToEBITDA": "-0.73",
    "Beta": "-0.076",
    "52WeekHigh": "315",
    "52WeekLow": "2.3",
    "50DayMovingAverage": "4.033",
    "200DayMovingAverage": "45.93",
    "SharesOutstanding": "1927900",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BEKE": {
    "Symbol": "BEKE",
    "AssetType": "Common Stock",
    "Name": "Ke Holdings Inc",
    "Description": "KE Holdings Inc. is involved in the operation of an integrated online and offline platform for housing transactions and services in the People's Republic of China. The company is headquartered in Beijing, China.",
    "CIK": "1809587",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "China",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "REAL ESTATE AGENTS & MANAGERS (FOR OTHERS)",
    "Address": "BUILDING FUDAO, NO. 11 KAITUO ROAD, BEIJING, CHINA",
    "OfficialSite": "https://ke.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "24426652000",
    "EBITDA": "3763308000",
    "PERatio": "41.59",
    "PEGRatio": "1.747",
    "BookValue": "60.61",
    "DividendPerShare": "2.489",
    "DividendYield": "0.0168",
    "EPS": "0.49",
    "RevenuePerShareTTM": "72.15",
    "ProfitMargin": "0.0505",
    "OperatingMarginTTM": "0.0322",
    "ReturnOnAssetsTTM": "0.0139",
    "ReturnOnEquityTTM": "0.0584",
    "RevenueTTM": "82536620000",
    "GrossProfitTTM": "20917916000",
    "DilutedEPSTTM": "0.49",
    "QuarterlyEarningsGrowthYOY": "0.031",
    "QuarterlyRevenueGrowthYOY": "0.268",
    "AnalystTargetPrice": "24.69",
    "AnalystRatingStrongBuy": "6",
    "AnalystRatingBuy": "14",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "41.59",
    "ForwardPE": "18.87",
    "PriceToSalesRatioTTM": "0.296",
    "PriceToBookRatio": "2.575",
    "EVToRevenue": "1.82",
    "EVToEBITDA": "26.42",
    "Beta": "-0.757",
    "52WeekHigh": "26.05",
    "52WeekLow": "12.14",
    "50DayMovingAverage": "18.3",
    "200DayMovingAverage": "17.53",
    "SharesOutstanding": "1148940000",
    "DividendDate": "2024-04-24",
    "ExDividendDate": "2024-04-04"
  },
  "HCTI": {
    "Symbol": "HCTI",
    "AssetType": "Common Stock",
    "Name": "Healthcare Triangle Inc",
    "Description": "Healthcare Triangle, Inc. is a healthcare information technology company. The company is headquartered in Pleasanton, California.",
    "CIK": "1839285",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN",
    "Address": "4309 HACIENDA DR., SUITE 150, PLEASANTON, CA, US",
    "OfficialSite": "https://www.healthcaretriangle.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "2154200",
    "EBITDA": "-3395000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-0.321",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.17",
    "RevenuePerShareTTM": "3.377",
    "ProfitMargin": "-0.601",
    "OperatingMarginTTM": "-0.484",
    "ReturnOnAssetsTTM": "-0.603",
    "ReturnOnEquityTTM": "-4.62",
    "RevenueTTM": "16566000",
    "GrossProfitTTM": "4164000",
    "DilutedEPSTTM": "-2.17",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.69",
    "AnalystTargetPrice": "1.5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.13",
    "PriceToBookRatio": "0.868",
    "EVToRevenue": "0.191",
    "EVToEBITDA": "-2.924",
    "Beta": "-0.007",
    "52WeekHigh": "2.96",
    "52WeekLow": "0.29",
    "50DayMovingAverage": "0.82",
    "200DayMovingAverage": "0.724",
    "SharesOutstanding": "6401800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SLNH": {
    "Symbol": "SLNH",
    "AssetType": "Common Stock",
    "Name": "Soluna Holdings Inc",
    "Description": "None",
    "CIK": "64463",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "MEASURING & CONTROLLING DEVICES, NEC",
    "Address": "325 WASHINGTON AVENUE EXTENSION, ALBANY, NY, US",
    "OfficialSite": "https://www.solunacomputing.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "12410200",
    "EBITDA": "1211000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "2.728",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-9.63",
    "RevenuePerShareTTM": "9.27",
    "ProfitMargin": "-0.753",
    "OperatingMarginTTM": "-1.198",
    "ReturnOnAssetsTTM": "-0.0941",
    "ReturnOnEquityTTM": "-0.463",
    "RevenueTTM": "39867000",
    "GrossProfitTTM": "27606000",
    "DilutedEPSTTM": "-9.63",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.298",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.311",
    "PriceToBookRatio": "0.595",
    "EVToRevenue": "0.748",
    "EVToEBITDA": "-0.625",
    "Beta": "3.007",
    "52WeekHigh": "8.8",
    "52WeekLow": "1",
    "50DayMovingAverage": "2.105",
    "200DayMovingAverage": "3.491",
    "SharesOutstanding": "10607000",
    "DividendDate": "2019-03-20",
    "ExDividendDate": "2019-03-21"
  },
  "LI": {
    "Symbol": "LI",
    "AssetType": "Common Stock",
    "Name": "Li Auto Inc",
    "Description": "Li Auto Inc. designs, develops, manufactures and sells smart electric sport utility vehicles (SUVs) in China. The company is headquartered in Beijing, China.",
    "CIK": "1791706",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "MANUFACTURING",
    "Industry": "MOTOR VEHICLES & PASSENGER CAR BODIES",
    "Address": "8TH FLOOR, BLOCK D, BUILDING 8, 4TH DISTRICT OF WANGJING EAST GARDEN, BEIJING, CHINA",
    "OfficialSite": "https://www.lixiang.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "28656220000",
    "EBITDA": "8252934000",
    "PERatio": "19.97",
    "PEGRatio": "1.425",
    "BookValue": "66.73",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "1.32",
    "RevenuePerShareTTM": "142.77",
    "ProfitMargin": "0.0716",
    "OperatingMarginTTM": "0.0801",
    "ReturnOnAssetsTTM": "0.0289",
    "ReturnOnEquityTTM": "0.17",
    "RevenueTTM": "141918372000",
    "GrossProfitTTM": "30472802000",
    "DilutedEPSTTM": "1.32",
    "QuarterlyEarningsGrowthYOY": "-0.007",
    "QuarterlyRevenueGrowthYOY": "0.236",
    "AnalystTargetPrice": "30.17",
    "AnalystRatingStrongBuy": "7",
    "AnalystRatingBuy": "16",
    "AnalystRatingHold": "4",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "19.97",
    "ForwardPE": "17.89",
    "PriceToSalesRatioTTM": "0.202",
    "PriceToBookRatio": "3.187",
    "EVToRevenue": "0.941",
    "EVToEBITDA": "13.86",
    "Beta": "0.912",
    "52WeekHigh": "46.02",
    "52WeekLow": "17.44",
    "50DayMovingAverage": "23.9",
    "200DayMovingAverage": "22.59",
    "SharesOutstanding": "883104000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SMCI": {
    "Symbol": "SMCI",
    "AssetType": "Common Stock",
    "Name": "Super Micro Computer Inc",
    "Description": "Super Micro Computer, Inc. develops and manufactures high-performance server and storage solutions based on an open, modular architecture. The company is headquartered in San Jose, California.",
    "CIK": "1375365",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "ELECTRONIC COMPUTERS",
    "Address": "980 ROCK AVENUE, SAN JOSE, CA, US",
    "OfficialSite": "https://www.supermicro.com",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "30221009000",
    "EBITDA": "1304591000",
    "PERatio": "25.68",
    "PEGRatio": "0.76",
    "BookValue": "9.32",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "2.01",
    "RevenuePerShareTTM": "26.88",
    "ProfitMargin": "0.0809",
    "OperatingMarginTTM": "0.0647",
    "ReturnOnAssetsTTM": "0.116",
    "ReturnOnEquityTTM": "0.325",
    "RevenueTTM": "14942854000",
    "GrossProfitTTM": "2111729000",
    "DilutedEPSTTM": "2.01",
    "QuarterlyEarningsGrowthYOY": "0.61",
    "QuarterlyRevenueGrowthYOY": "1.43",
    "AnalystTargetPrice": "47.88",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "6",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "25.68",
    "ForwardPE": "21.14",
    "PriceToSalesRatioTTM": "2.022",
    "PriceToBookRatio": "6.0",
    "EVToRevenue": "2.23",
    "EVToEBITDA": "25.87",
    "Beta": "1.297",
    "52WeekHigh": "122.9",
    "52WeekLow": "17.25",
    "50DayMovingAverage": "35.65",
    "200DayMovingAverage": "53.22",
    "SharesOutstanding": "585565000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BABA": {
    "Symbol": "BABA",
    "AssetType": "Common Stock",
    "Name": "Alibaba Group Holding Ltd",
    "Description": "Alibaba Group Holding Limited, also known as Alibaba Group and Alibaba.com, is a Chinese multinational technology company specializing in e-commerce, retail, Internet, and technology. Founded on 28 June 1999 in Hangzhou, Zhejiang, the company provides consumer-to-consumer (C2C), business-to-consumer (B2C), and business-to-business (B2B) sales services via web portals, as well as electronic payment services, shopping search engines and cloud computing services. It owns and operates a diverse portfolio of companies around the world in numerous business sectors.",
    "CIK": "1577552",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-BUSINESS SERVICES, NEC",
    "Address": "26/F TOWER ONE, TIMES SQUARE, 1 MATHESON STREET, CAUSEWAY BAY, HK",
    "OfficialSite": "https://www.alibabagroup.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "331947639000",
    "EBITDA": "179009995000",
    "PERatio": "18.76",
    "PEGRatio": "0.841",
    "BookValue": "432.52",
    "DividendPerShare": "7.22",
    "DividendYield": "0.0155",
    "EPS": "6.88",
    "RevenuePerShareTTM": "411.01",
    "ProfitMargin": "0.123",
    "OperatingMarginTTM": "0.171",
    "ReturnOnAssetsTTM": "0.0504",
    "ReturnOnEquityTTM": "0.103",
    "RevenueTTM": "981767029000",
    "GrossProfitTTM": "381009986000",
    "DilutedEPSTTM": "6.88",
    "QuarterlyEarningsGrowthYOY": "2.608",
    "QuarterlyRevenueGrowthYOY": "0.076",
    "AnalystTargetPrice": "153.63",
    "AnalystRatingStrongBuy": "8",
    "AnalystRatingBuy": "26",
    "AnalystRatingHold": "7",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "18.76",
    "ForwardPE": "14.88",
    "PriceToSalesRatioTTM": "0.338",
    "PriceToBookRatio": "2.476",
    "EVToRevenue": "2.276",
    "EVToEBITDA": "13.19",
    "Beta": "0.308",
    "52WeekHigh": "145.3",
    "52WeekLow": "67.78",
    "50DayMovingAverage": "95.1",
    "200DayMovingAverage": "88.26",
    "SharesOutstanding": "2375950000",
    "DividendDate": "2024-07-12",
    "ExDividendDate": "2024-06-13"
  },
  "XPEV": {
    "Symbol": "XPEV",
    "AssetType": "Common Stock",
    "Name": "Xpeng Inc",
    "Description": "XPeng Inc. designs, develops, manufactures and markets smart electric vehicles in the People's Republic of China. The company is headquartered in Guangzhou, the People's Republic of China.",
    "CIK": "1810997",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "MOTOR VEHICLES & PASSENGER CAR BODIES",
    "Address": "NO. 8 SONGGANG ROAD, CHANGXING STREET, CENCUN, TIANHE DISTRICT, GUANGZHOU, GUANGDONG, GH",
    "OfficialSite": "https://www.xpeng.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "17284626000",
    "EBITDA": "-4537026048",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "33.82",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.21",
    "RevenuePerShareTTM": "40.57",
    "ProfitMargin": "-0.154",
    "OperatingMarginTTM": "-0.167",
    "ReturnOnAssetsTTM": "-0.0607",
    "ReturnOnEquityTTM": "-0.191",
    "RevenueTTM": "37811642000",
    "GrossProfitTTM": "4412277000",
    "DilutedEPSTTM": "-1.21",
    "QuarterlyEarningsGrowthYOY": "-0.385",
    "QuarterlyRevenueGrowthYOY": "0.184",
    "AnalystTargetPrice": "15.46",
    "AnalystRatingStrongBuy": "4",
    "AnalystRatingBuy": "16",
    "AnalystRatingHold": "6",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.457",
    "PriceToBookRatio": "3.968",
    "EVToRevenue": "3.269",
    "EVToEBITDA": "-0.747",
    "Beta": "2.766",
    "52WeekHigh": "19.47",
    "52WeekLow": "6.55",
    "50DayMovingAverage": "14.22",
    "200DayMovingAverage": "10.68",
    "SharesOutstanding": "773790000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "CPOP": {
    "Symbol": "CPOP",
    "AssetType": "Common Stock",
    "Name": "Pop Culture Group Co Ltd",
    "Description": "Pop Culture Group Co., Ltd organizes entertainment events for corporate clients in China. The company is headquartered in Xiamen, China.",
    "CIK": "1807389",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-AMUSEMENT & RECREATION SERVICES",
    "Address": "3RD FL, NO 168 FENGQI RD, JIMEI DISTRICT, XIAMEN CITY, FUJIAN PROVINCE, XIAMEN, CHINA",
    "OfficialSite": "https://www.cpop.cn",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "9840300",
    "EBITDA": "-8043688",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "3.886",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-4.32",
    "RevenuePerShareTTM": "16.49",
    "ProfitMargin": "-0.262",
    "OperatingMarginTTM": "-0.259",
    "ReturnOnAssetsTTM": "-0.13",
    "ReturnOnEquityTTM": "-0.609",
    "RevenueTTM": "47381900",
    "GrossProfitTTM": "2880700",
    "DilutedEPSTTM": "-4.32",
    "QuarterlyEarningsGrowthYOY": "-0.861",
    "QuarterlyRevenueGrowthYOY": "2.207",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.208",
    "PriceToBookRatio": "0.643",
    "EVToRevenue": "0.316",
    "EVToEBITDA": "4.573",
    "Beta": "1.752",
    "52WeekHigh": "4.3",
    "52WeekLow": "0.61",
    "50DayMovingAverage": "0.975",
    "200DayMovingAverage": "1.227",
    "SharesOutstanding": "14362700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BLMZ": {
    "Symbol": "BLMZ",
    "AssetType": "Common Stock",
    "Name": "BloomZ Inc. Ordinary Shares",
    "Description": "Bloomz, Inc. develops and delivers a web and mobile application that allows teachers to communicate with parents, share class photos and updates, and coordinate through volunteer and conference signups. The company is headquartered in Redmond, Washington.",
    "CIK": "None",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "GENERAL",
    "Address": "NONE",
    "OfficialSite": "https://www.bloomz-inc.com",
    "FiscalYearEnd": "September",
    "LatestQuarter": "2023-09-30",
    "MarketCapitalization": "25785200",
    "EBITDA": "-6621000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "20.46",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.01",
    "RevenuePerShareTTM": "15.17",
    "ProfitMargin": "-0.123",
    "OperatingMarginTTM": "-0.0959",
    "ReturnOnAssetsTTM": "-0.0452",
    "ReturnOnEquityTTM": "-0.132",
    "RevenueTTM": "128313000",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-0.01",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.206",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.201",
    "PriceToBookRatio": "16.07",
    "EVToRevenue": "28.33",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "4.3",
    "52WeekLow": "0.329",
    "50DayMovingAverage": "1.519",
    "200DayMovingAverage": "1.519",
    "SharesOutstanding": "13429800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "ULY": {
    "Symbol": "ULY",
    "AssetType": "Common Stock",
    "Name": "Urgent.ly Inc. Common Stock",
    "Description": "None",
    "CIK": "1603652",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROCESSING & DATA PREPARATION",
    "Address": "8609 WESTWOOD CENTER DRIVE, SUITE 810, VIENNA, VA, UNITED STATES",
    "OfficialSite": "https://www.geturgently.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "5669900",
    "EBITDA": "-27791000",
    "PERatio": "0.061",
    "PEGRatio": "None",
    "BookValue": "-1.75",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "6.88",
    "RevenuePerShareTTM": "12.27",
    "ProfitMargin": "0.593",
    "OperatingMarginTTM": "-0.145",
    "ReturnOnAssetsTTM": "-0.4",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "155926000",
    "GrossProfitTTM": "34630000",
    "DilutedEPSTTM": "6.88",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.213",
    "AnalystTargetPrice": "1.5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "0.061",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.0364",
    "PriceToBookRatio": "2.263",
    "EVToRevenue": "0.278",
    "EVToEBITDA": "0.382",
    "Beta": "None",
    "52WeekHigh": "3.45",
    "52WeekLow": "0.411",
    "50DayMovingAverage": "0.503",
    "200DayMovingAverage": "0.998",
    "SharesOutstanding": "13499700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "ICCT": {
    "Symbol": "ICCT",
    "AssetType": "Common Stock",
    "Name": "iCoreConnect Inc. Common stock",
    "Description": "iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company is headquartered in Ocoee, Florida.",
    "CIK": "1906133",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-PREPACKAGED SOFTWARE",
    "Address": "529 E. CROWN POINT ROAD, SUITE 250, OCOEE, FL, UNITED STATES",
    "OfficialSite": "https://www.icoreconnect.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "1426200",
    "EBITDA": "-14429196",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-5.11",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-63.2",
    "RevenuePerShareTTM": "21.86",
    "ProfitMargin": "-2.631",
    "OperatingMarginTTM": "-0.789",
    "ReturnOnAssetsTTM": "-0.699",
    "ReturnOnEquityTTM": "-17.18",
    "RevenueTTM": "11049500",
    "GrossProfitTTM": "8567000",
    "DilutedEPSTTM": "-63.2",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.391",
    "AnalystTargetPrice": "0.5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.129",
    "PriceToBookRatio": "8.91",
    "EVToRevenue": "1.212",
    "EVToEBITDA": "-7.48",
    "Beta": "1.083",
    "52WeekHigh": "35.8",
    "52WeekLow": "0.63",
    "50DayMovingAverage": "2.362",
    "200DayMovingAverage": "8.97",
    "SharesOutstanding": "2073000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "TRNR": {
    "Symbol": "TRNR",
    "AssetType": "Common Stock",
    "Name": "Interactive Strength Inc. Common Stock",
    "Description": "None",
    "CIK": "1785056",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP)",
    "Address": "1005 CONGRESS AVE, SUITE 925, AUSTIN, TX, UNITED STATES",
    "OfficialSite": "https://formelife.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "2244000",
    "EBITDA": "-31673000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-15.65",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-4516",
    "RevenuePerShareTTM": "3.389",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-12.35",
    "ReturnOnAssetsTTM": "-0.792",
    "ReturnOnEquityTTM": "-16.17",
    "RevenueTTM": "1473000",
    "GrossProfitTTM": "-8868000",
    "DilutedEPSTTM": "-4516",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.965",
    "AnalystTargetPrice": "60",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.01",
    "PriceToBookRatio": "0.554",
    "EVToRevenue": "4.884",
    "EVToEBITDA": "-0.226",
    "Beta": "None",
    "52WeekHigh": "1640",
    "52WeekLow": "0.855",
    "50DayMovingAverage": "14.94",
    "200DayMovingAverage": "597.68",
    "SharesOutstanding": "625070",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "VMAR": {
    "Symbol": "VMAR",
    "AssetType": "Common Stock",
    "Name": "Vision Marine Technologies Inc",
    "Description": "Vision Marine Technologies Inc., operating as the Canadian Electric Boat Company, designs, manufactures, leases and sells electric boats in Canada. The company is headquartered in Boisbriand, Canada.",
    "CIK": "1813783",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "SHIP & BOAT BUILDING & REPAIRING",
    "Address": "730 BOULEVARD DU CURE-BOIVIN, BOISBRAIND, CANADA (FEDERAL LEVEL)",
    "OfficialSite": "https://visionmarinetechnologies.com",
    "FiscalYearEnd": "August",
    "LatestQuarter": "2024-11-30",
    "MarketCapitalization": "7333800",
    "EBITDA": "-11665140",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "5.83",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-117.35",
    "RevenuePerShareTTM": "10.85",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-20.9",
    "ReturnOnAssetsTTM": "-0.411",
    "ReturnOnEquityTTM": "-1.435",
    "RevenueTTM": "2950400",
    "GrossProfitTTM": "1011500",
    "DilutedEPSTTM": "-117.35",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.856",
    "AnalystTargetPrice": "260.8",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "2.486",
    "PriceToBookRatio": "1.167",
    "EVToRevenue": "3.521",
    "EVToEBITDA": "-2.484",
    "Beta": "-0.111",
    "52WeekHigh": "108",
    "52WeekLow": "0.705",
    "50DayMovingAverage": "1.45",
    "200DayMovingAverage": "29.53",
    "SharesOutstanding": "9778400",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "NIXX": {
    "Symbol": "NIXX",
    "AssetType": "Common Stock",
    "Name": "Nixxy, Inc.",
    "Description": "None",
    "CIK": "1462223",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SPECIAL INDUSTRY MACHINERY, NEC",
    "Address": "1174 N. HILLCREST ROAD, BEVERLY HILLS, CA, US",
    "OfficialSite": "https://www.recruiter.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "41084200",
    "EBITDA": "-7998205",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.561",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-5.85",
    "RevenuePerShareTTM": "0.237",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-40.43",
    "ReturnOnAssetsTTM": "-0.505",
    "ReturnOnEquityTTM": "-3.898",
    "RevenueTTM": "668690",
    "GrossProfitTTM": "107810",
    "DilutedEPSTTM": "-5.85",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.26",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "61.44",
    "PriceToBookRatio": "6.01",
    "EVToRevenue": "59.7",
    "EVToEBITDA": "-0.748",
    "Beta": "1.003",
    "52WeekHigh": "6.25",
    "52WeekLow": "1.2",
    "50DayMovingAverage": "4.094",
    "200DayMovingAverage": "2.682",
    "SharesOutstanding": "14939700",
    "DividendDate": "2019-08-22",
    "ExDividendDate": "None"
  },
  "MARA": {
    "Symbol": "MARA",
    "AssetType": "Common Stock",
    "Name": "Marathon Digital Holdings Inc",
    "Description": "Marathon Digital Holdings, Inc. is a cryptocurrency mining digital asset technology company with a focus on the blockchain ecosystem and digital asset generation in the United States. The company is headquartered in Las Vegas, Nevada.",
    "CIK": "1507605",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "PATENT OWNERS & LESSORS",
    "Address": "1180 N. TOWN CENTER DRIVE, SUITE 100, LAS VEGAS, NV, US",
    "OfficialSite": "https://www.mara.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "4213428000",
    "EBITDA": "330969000",
    "PERatio": "14.96",
    "PEGRatio": "0",
    "BookValue": "9.37",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.83",
    "RevenuePerShareTTM": "2.258",
    "ProfitMargin": "0.275",
    "OperatingMarginTTM": "-1.016",
    "ReturnOnAssetsTTM": "-0.0075",
    "ReturnOnEquityTTM": "0.0849",
    "RevenueTTM": "598752000",
    "GrossProfitTTM": "242016000",
    "DilutedEPSTTM": "0.83",
    "QuarterlyEarningsGrowthYOY": "0.764",
    "QuarterlyRevenueGrowthYOY": "0.345",
    "AnalystTargetPrice": "26.92",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "9",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "14.96",
    "ForwardPE": "39.53",
    "PriceToSalesRatioTTM": "7.04",
    "PriceToBookRatio": "1.651",
    "EVToRevenue": "8.67",
    "EVToEBITDA": "10.28",
    "Beta": "5.77",
    "52WeekHigh": "30.71",
    "52WeekLow": "12.05",
    "50DayMovingAverage": "18.69",
    "200DayMovingAverage": "19.06",
    "SharesOutstanding": "339382000",
    "DividendDate": "2019-04-08",
    "ExDividendDate": "None"
  },
  "CLSK": {
    "Symbol": "CLSK",
    "AssetType": "Common Stock",
    "Name": "CleanSpark Inc",
    "Description": "CleanSpark, Inc. provides energy software and control technology solutions worldwide. The company is headquartered in Woods Cross, Utah.",
    "CIK": "827876",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "BLANK CHECKS",
    "Address": "PO BOX 1593, MOAB, UT, US",
    "OfficialSite": "https://www.cleanspark.com",
    "FiscalYearEnd": "September",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "2288585000",
    "EBITDA": "425564000",
    "PERatio": "0",
    "PEGRatio": "0",
    "BookValue": "7.2",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0",
    "RevenuePerShareTTM": "1.921",
    "ProfitMargin": "0.161",
    "OperatingMarginTTM": "1.291",
    "ReturnOnAssetsTTM": "0.0805",
    "ReturnOnEquityTTM": "0.053",
    "RevenueTTM": "467488000",
    "GrossProfitTTM": "260578000",
    "DilutedEPSTTM": "0",
    "QuarterlyEarningsGrowthYOY": "4.916",
    "QuarterlyRevenueGrowthYOY": "1.2",
    "AnalystTargetPrice": "22.75",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "7.34",
    "PriceToSalesRatioTTM": "4.896",
    "PriceToBookRatio": "1.132",
    "EVToRevenue": "3.702",
    "EVToEBITDA": "6.16",
    "Beta": "4.252",
    "52WeekHigh": "24.72",
    "52WeekLow": "7.7",
    "50DayMovingAverage": "10.75",
    "200DayMovingAverage": "12.91",
    "SharesOutstanding": "280808000",
    "DividendDate": "2019-12-11",
    "ExDividendDate": "2021-06-21"
  },
  "RXRX": {
    "Symbol": "RXRX",
    "AssetType": "Common Stock",
    "Name": "Recursion Pharmaceuticals Inc",
    "Description": "Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.",
    "CIK": "1601830",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)",
    "Address": "41S RIO GRANDE STREET, SALT LAKE CITY, UT, US",
    "OfficialSite": "https://www.recursion.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "3180477000",
    "EBITDA": "-364150016",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "1.833",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.54",
    "RevenuePerShareTTM": "0.265",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-3.771",
    "ReturnOnAssetsTTM": "-0.364",
    "ReturnOnEquityTTM": "-0.785",
    "RevenueTTM": "65184000",
    "GrossProfitTTM": "-262710000",
    "DilutedEPSTTM": "-1.54",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "1.476",
    "AnalystTargetPrice": "9.14",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "1",
    "AnalystRatingHold": "6",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "48.79",
    "PriceToBookRatio": "6.06",
    "EVToRevenue": "44.02",
    "EVToEBITDA": "-5.31",
    "Beta": "0.859",
    "52WeekHigh": "14.12",
    "52WeekLow": "5.6",
    "50DayMovingAverage": "7.56",
    "200DayMovingAverage": "7.48",
    "SharesOutstanding": "383724000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "LUNR": {
    "Symbol": "LUNR",
    "AssetType": "Common Stock",
    "Name": "Intuitive Machines Inc. ",
    "Description": "None",
    "CIK": "1844452",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "SEARCH, DETECTION, NAVAGATION, GUIDANCE, AERONAUTICAL SYS",
    "Address": "34 EAST 51ST STREET, 5TH FLOOR, NEW YORK, NY, US",
    "OfficialSite": "https://www.intuitivemachines.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "1426186000",
    "EBITDA": "-38849000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-6.2",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.22",
    "RevenuePerShareTTM": "4.515",
    "ProfitMargin": "-0.865",
    "OperatingMarginTTM": "-0.148",
    "ReturnOnAssetsTTM": "-0.155",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "203899000",
    "GrossProfitTTM": "5867000",
    "DilutedEPSTTM": "-2.22",
    "QuarterlyEarningsGrowthYOY": "-0.81",
    "QuarterlyRevenueGrowthYOY": "3.593",
    "AnalystTargetPrice": "18",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "6.99",
    "PriceToBookRatio": "-",
    "EVToRevenue": "7.49",
    "EVToEBITDA": "21.05",
    "Beta": "0.92",
    "52WeekHigh": "24.95",
    "52WeekLow": "3.15",
    "50DayMovingAverage": "18.36",
    "200DayMovingAverage": "9.5",
    "SharesOutstanding": "92610000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BCG": {
    "Symbol": "BCG",
    "AssetType": "Common Stock",
    "Name": "Binah Capital Group, Inc. Common Stock",
    "Description": "None",
    "CIK": "1953984",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "FINANCE",
    "Industry": "FINANCE SERVICES",
    "Address": "80 STATE STREET, ALBANY, NY, UNITED STATES",
    "OfficialSite": "https://www.wentworthms.com",
    "FiscalYearEnd": "September",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "46653000",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.163",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.18",
    "RevenuePerShareTTM": "9.75",
    "ProfitMargin": "-0.0182",
    "OperatingMarginTTM": "-0.0131",
    "ReturnOnAssetsTTM": "-0.0443",
    "ReturnOnEquityTTM": "-0.254",
    "RevenueTTM": "161897000",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-0.18",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.023",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.288",
    "PriceToBookRatio": "17.21",
    "EVToRevenue": "0.432",
    "EVToEBITDA": "29.92",
    "Beta": "0.429",
    "52WeekHigh": "16.61",
    "52WeekLow": "1.71",
    "50DayMovingAverage": "4.058",
    "200DayMovingAverage": "5.73",
    "SharesOutstanding": "16602500",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "PEPG": {
    "Symbol": "PEPG",
    "AssetType": "Common Stock",
    "Name": "PepGen Ltd",
    "Description": "PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts.",
    "CIK": "1835597",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA, US",
    "OfficialSite": "https://pepgen.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "55904000",
    "EBITDA": "-96234000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "3.636",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.55",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.416",
    "ReturnOnEquityTTM": "-0.793",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-2.55",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "12.2",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "0.471",
    "EVToRevenue": "-",
    "EVToEBITDA": "-3.115",
    "Beta": "1.525",
    "52WeekHigh": "19.3",
    "52WeekLow": "1.16",
    "50DayMovingAverage": "2.644",
    "200DayMovingAverage": "8.98",
    "SharesOutstanding": "32692400",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "XNET": {
    "Symbol": "XNET",
    "AssetType": "Common Stock",
    "Name": "Xunlei Ltd Adr",
    "Description": "Xunlei Limited, operates an Internet platform for digital media content in the People's Republic of China. The company is headquartered in Shenzhen, the People's Republic of China.",
    "CIK": "1510593",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-PREPACKAGED SOFTWARE",
    "Address": "7/F, BLDG 11, SHENZHEN SOFTWARE PARK II, SHENZHEN HIGH-TECH PARK, SHENZHEN, CHINA",
    "OfficialSite": "https://www.xunlei.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "183837000",
    "EBITDA": "8524000",
    "PERatio": "11.15",
    "PEGRatio": "0",
    "BookValue": "5.32",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.26",
    "RevenuePerShareTTM": "5.65",
    "ProfitMargin": "0.0401",
    "OperatingMarginTTM": "0.0651",
    "ReturnOnAssetsTTM": "0.0022",
    "ReturnOnEquityTTM": "0.0436",
    "RevenueTTM": "359611000",
    "GrossProfitTTM": "165991000",
    "DilutedEPSTTM": "0.26",
    "QuarterlyEarningsGrowthYOY": "-0.435",
    "QuarterlyRevenueGrowthYOY": "-0.237",
    "AnalystTargetPrice": "12",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "11.15",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.511",
    "PriceToBookRatio": "0.545",
    "EVToRevenue": "0.131",
    "EVToEBITDA": "-5.84",
    "Beta": "1.062",
    "52WeekHigh": "4.805",
    "52WeekLow": "1.45",
    "50DayMovingAverage": "2.441",
    "200DayMovingAverage": "1.962",
    "SharesOutstanding": "63392000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MULN": {
    "Symbol": "MULN",
    "AssetType": "Common Stock",
    "Name": "Mullen Automotive Inc.",
    "Description": "None",
    "CIK": "1499961",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROCESSING & DATA PREPARATION",
    "Address": "3363 NE 163RD STREET, SUITE 705, NORTH MIAMI BEACH, FL, US",
    "OfficialSite": "https://www.mullenusa.com",
    "FiscalYearEnd": "September",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "2003900",
    "EBITDA": "-242281648",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-254.93",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1297.09",
    "RevenuePerShareTTM": "82.3",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-17.61",
    "ReturnOnAssetsTTM": "-0.597",
    "ReturnOnEquityTTM": "-6.31",
    "RevenueTTM": "4014800",
    "GrossProfitTTM": "-19468226",
    "DilutedEPSTTM": "-1297.09",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "16.17",
    "AnalystTargetPrice": "23",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.499",
    "PriceToBookRatio": "0.354",
    "EVToRevenue": "6.81",
    "EVToEBITDA": "0.0552",
    "Beta": "0.925",
    "52WeekHigh": "47100",
    "52WeekLow": "1.82",
    "50DayMovingAverage": "28.57",
    "200DayMovingAverage": "4855.99",
    "SharesOutstanding": "1083200",
    "DividendDate": "2017-10-05",
    "ExDividendDate": "None"
  },
  "ENTO": {
    "Symbol": "ENTO",
    "AssetType": "Common Stock",
    "Name": "Entero Therapeutics, Inc.",
    "Description": "Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company is headquartered in Boca Raton, Florida.",
    "CIK": "1604191",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "777 YAMATO ROAD, SUITE 502, BOCA RATON, FL, US",
    "OfficialSite": "https://www.enterothera.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "1106100",
    "EBITDA": "-20899808",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "7.99",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-11.04",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.271",
    "ReturnOnEquityTTM": "-0.153",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-11.04",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "36",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "0.0684",
    "EVToRevenue": "-",
    "EVToEBITDA": "-0.1",
    "Beta": "1.373",
    "52WeekHigh": "8.45",
    "52WeekLow": "0.185",
    "50DayMovingAverage": "0.578",
    "200DayMovingAverage": "3.146",
    "SharesOutstanding": "3253300",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "POLA": {
    "Symbol": "POLA",
    "AssetType": "Common Stock",
    "Name": "Polar Power Inc",
    "Description": "Polar Power, Inc. designs, manufactures, and sells direct current (DC), power generators, renewable energy, and cooling systems in the United States and internationally. The company is headquartered in Gardena, California.",
    "CIK": "1622345",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES",
    "Address": "249 E. GARDENA BOULEVARD, GARDENA, CA, US",
    "OfficialSite": "https://www.polarpower.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "7250400",
    "EBITDA": "-5883000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.751",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.24",
    "RevenuePerShareTTM": "0.766",
    "ProfitMargin": "-0.556",
    "OperatingMarginTTM": "0.0987",
    "ReturnOnAssetsTTM": "-0.153",
    "ReturnOnEquityTTM": "-0.471",
    "RevenueTTM": "11950000",
    "GrossProfitTTM": "3445000",
    "DilutedEPSTTM": "-2.24",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.166",
    "AnalystTargetPrice": "5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.467",
    "PriceToBookRatio": "0.602",
    "EVToRevenue": "0.906",
    "EVToEBITDA": "-4.272",
    "Beta": "0.945",
    "52WeekHigh": "4.9",
    "52WeekLow": "2.01",
    "50DayMovingAverage": "3.272",
    "200DayMovingAverage": "3.063",
    "SharesOutstanding": "2508800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SBET": {
    "Symbol": "SBET",
    "AssetType": "Common Stock",
    "Name": "Sharplink Gaming Ltd",
    "Description": "None",
    "CIK": "1981535",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-PREPACKAGED SOFTWARE",
    "Address": "333 WASHINGTON AVENUE NORTH, SUITE 104, SUITE 104, MINNEAPOLIS, MN, UNITED STATES",
    "OfficialSite": "https://www.sharplink.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "2315900",
    "EBITDA": "-5285426",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.563",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.71",
    "RevenuePerShareTTM": "1.203",
    "ProfitMargin": "1.519",
    "OperatingMarginTTM": "-0.904",
    "ReturnOnAssetsTTM": "-0.0759",
    "ReturnOnEquityTTM": "-19.18",
    "RevenueTTM": "3866000",
    "GrossProfitTTM": "1090600",
    "DilutedEPSTTM": "-2.71",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.347",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.599",
    "PriceToBookRatio": "1.137",
    "EVToRevenue": "3.266",
    "EVToEBITDA": "-0.184",
    "Beta": "1.343",
    "52WeekHigh": "1.68",
    "52WeekLow": "0.33",
    "50DayMovingAverage": "0.546",
    "200DayMovingAverage": "0.683",
    "SharesOutstanding": "6259100",
    "DividendDate": "2017-09-06",
    "ExDividendDate": "None"
  },
  "BTCT": {
    "Symbol": "BTCT",
    "AssetType": "Common Stock",
    "Name": "BTC Digital Ltd.",
    "Description": "BTC Digital Ltd. engages in the cryptocurrency/bitcoin mining business. The company is headquartered in Shenzhen, the People's Republic of China.",
    "CIK": "1796514",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "FINANCE",
    "Industry": "FINANCE SERVICES",
    "Address": "1306, 13TH FLOOR, XUESONG DASHA BUILDING B, SHENZHEN, CHINA",
    "OfficialSite": "https://btct.investorroom.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "21016400",
    "EBITDA": "619000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "6.2",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.08",
    "RevenuePerShareTTM": "3.433",
    "ProfitMargin": "-0.319",
    "OperatingMarginTTM": "-0.212",
    "ReturnOnAssetsTTM": "-0.0764",
    "ReturnOnEquityTTM": "-0.166",
    "RevenueTTM": "8482000",
    "GrossProfitTTM": "-1087000",
    "DilutedEPSTTM": "-1.08",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "2.028",
    "AnalystTargetPrice": "2.955",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "2.478",
    "PriceToBookRatio": "1.029",
    "EVToRevenue": "2.539",
    "EVToEBITDA": "25.13",
    "Beta": "2.564",
    "52WeekHigh": "24.8",
    "52WeekLow": "1.32",
    "50DayMovingAverage": "5.3",
    "200DayMovingAverage": "4.095",
    "SharesOutstanding": "5254100",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BTM": {
    "Symbol": "BTM",
    "AssetType": "Common Stock",
    "Name": "Bitcoin Depot Inc.",
    "Description": "Bitcoin Depot Inc. owns and operates a network of cryptocurrency kiosks in North America. The company is headquartered in Atlanta, Georgia.",
    "CIK": "1901799",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "FINANCE",
    "Industry": "FINANCE SERVICES",
    "Address": "4 VILLAGE ROW, NEW HOPE, PA, US",
    "OfficialSite": "https://www.bitcoindepot.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "23096700",
    "EBITDA": "28855000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-0.974",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.89",
    "RevenuePerShareTTM": "31.87",
    "ProfitMargin": "-0.0228",
    "OperatingMarginTTM": "0.0405",
    "ReturnOnAssetsTTM": "0.131",
    "ReturnOnEquityTTM": "-0.105",
    "RevenueTTM": "585282000",
    "GrossProfitTTM": "123592000",
    "DilutedEPSTTM": "-0.89",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.246",
    "AnalystTargetPrice": "4.688",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "9.91",
    "PriceToSalesRatioTTM": "0.0395",
    "PriceToBookRatio": "-",
    "EVToRevenue": "0.0807",
    "EVToEBITDA": "1.803",
    "Beta": "0.001",
    "52WeekHigh": "3.52",
    "52WeekLow": "0.926",
    "50DayMovingAverage": "1.542",
    "200DayMovingAverage": "1.681",
    "SharesOutstanding": "18122000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BTOG": {
    "Symbol": "BTOG",
    "AssetType": "Common Stock",
    "Name": "Bit Origin Ltd",
    "Description": "China Xiangtai Food Co., Ltd. is engaged in wholesale and retail of feed raw materials in China. The company is headquartered in Chongqing, China.",
    "CIK": "1735556",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "FINANCE",
    "Industry": "FINANCE SERVICES",
    "Address": "27F, SAMSUNG HUB, 3 CHURCH STREET, NY, SINGAPORE",
    "OfficialSite": "https://bitorigin.io",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2023-12-31",
    "MarketCapitalization": "2703400",
    "EBITDA": "-5072891",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.214",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-3.34",
    "RevenuePerShareTTM": "0.551",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-2.068",
    "ReturnOnAssetsTTM": "-0.373",
    "ReturnOnEquityTTM": "-3.274",
    "RevenueTTM": "2888500",
    "GrossProfitTTM": "-945202",
    "DilutedEPSTTM": "-3.34",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-1",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.936",
    "PriceToBookRatio": "0.927",
    "EVToRevenue": "1.833",
    "EVToEBITDA": "-4.794",
    "Beta": "1.245",
    "52WeekHigh": "6.04",
    "52WeekLow": "0.161",
    "50DayMovingAverage": "0.649",
    "200DayMovingAverage": "1.908",
    "SharesOutstanding": "8466800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "HMR": {
    "Symbol": "HMR",
    "AssetType": "Common Stock",
    "Name": "Heidmar Maritime Holdings Corp. Common Stock",
    "Description": "None",
    "CIK": "0001412203",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "GENERAL",
    "Address": "NONE",
    "OfficialSite": "",
    "FiscalYearEnd": "December",
    "LatestQuarter": "None",
    "MarketCapitalization": "None",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "None",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "None",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "0",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "-",
    "EVToRevenue": "-",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "0",
    "52WeekLow": "0",
    "50DayMovingAverage": "0",
    "200DayMovingAverage": "0",
    "SharesOutstanding": "0",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BTCS": {
    "Symbol": "BTCS",
    "AssetType": "Common Stock",
    "Name": "BTCS Inc",
    "Description": "BTCS Inc. focuses on blockchain technologies and digital currency ecosystems. The company is headquartered in Silver Spring, Maryland.",
    "CIK": "1436229",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-PREPACKAGED SOFTWARE",
    "Address": "1901 N MOORE ST, SUITE 700, ARLINGTON, VA, US",
    "OfficialSite": "https://www.btcs.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "40471300",
    "EBITDA": "-4612089",
    "PERatio": "7.34",
    "PEGRatio": "None",
    "BookValue": "1.367",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.29",
    "RevenuePerShareTTM": "0.134",
    "ProfitMargin": "1.831",
    "OperatingMarginTTM": "-2.168",
    "ReturnOnAssetsTTM": "-0.163",
    "ReturnOnEquityTTM": "0.226",
    "RevenueTTM": "2077900",
    "GrossProfitTTM": "1124000",
    "DilutedEPSTTM": "0.29",
    "QuarterlyEarningsGrowthYOY": "1.172",
    "QuarterlyRevenueGrowthYOY": "1.337",
    "AnalystTargetPrice": "5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "7.34",
    "ForwardPE": "3.04",
    "PriceToSalesRatioTTM": "19.48",
    "PriceToBookRatio": "1.788",
    "EVToRevenue": "8.18",
    "EVToEBITDA": "-1.258",
    "Beta": "3.08",
    "52WeekHigh": "5.41",
    "52WeekLow": "0.95",
    "50DayMovingAverage": "2.769",
    "200DayMovingAverage": "1.976",
    "SharesOutstanding": "19000600",
    "DividendDate": "2019-04-10",
    "ExDividendDate": "2022-03-16"
  },
  "ARBK": {
    "Symbol": "ARBK",
    "AssetType": "Common Stock",
    "Name": "Argo Blockchain PLC ADR",
    "Description": "None",
    "CIK": "1841675",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "FINANCE",
    "Industry": "FINANCE SERVICES",
    "Address": "EASTCASTLE HOUSE, 27/28 EASTCASTLE STREET, LONDON, GB",
    "OfficialSite": "https://www.argoblockchain.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "35095800",
    "EBITDA": "5044000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-0.035",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.9",
    "RevenuePerShareTTM": "0.99",
    "ProfitMargin": "-0.909",
    "OperatingMarginTTM": "-0.483",
    "ReturnOnAssetsTTM": "-0.154",
    "ReturnOnEquityTTM": "-4.386",
    "RevenueTTM": "52868000",
    "GrossProfitTTM": "17105000",
    "DilutedEPSTTM": "-0.9",
    "QuarterlyEarningsGrowthYOY": "-0.94",
    "QuarterlyRevenueGrowthYOY": "-0.283",
    "AnalystTargetPrice": "0.25",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "3",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "100",
    "PriceToSalesRatioTTM": "0.664",
    "PriceToBookRatio": "8.39",
    "EVToRevenue": "1.106",
    "EVToEBITDA": "129.44",
    "Beta": "3.469",
    "52WeekHigh": "2.48",
    "52WeekLow": "0.405",
    "50DayMovingAverage": "0.549",
    "200DayMovingAverage": "1.056",
    "SharesOutstanding": "63635000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MIGI": {
    "Symbol": "MIGI",
    "AssetType": "Common Stock",
    "Name": "Mawson Infrastructure Group Inc",
    "Description": "Mawson Infrastructure Group Inc., a digital infrastructure provider, operates cryptocurrency mining and digital asset infrastructure activities in the United States and Australia. The company is headquartered in North Sydney, Australia.",
    "CIK": "1218683",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "10 BAREKET STREET, PETACH TIKVA, IL",
    "OfficialSite": "https://www.mawsoninc.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "10831700",
    "EBITDA": "-13509532",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-0.083",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-3.13",
    "RevenuePerShareTTM": "3.364",
    "ProfitMargin": "-0.937",
    "OperatingMarginTTM": "-0.861",
    "ReturnOnAssetsTTM": "-0.33",
    "ReturnOnEquityTTM": "-2.701",
    "RevenueTTM": "58216000",
    "GrossProfitTTM": "20504500",
    "DilutedEPSTTM": "-3.13",
    "QuarterlyEarningsGrowthYOY": "-0.977",
    "QuarterlyRevenueGrowthYOY": "0.087",
    "AnalystTargetPrice": "3",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "5.53",
    "PriceToSalesRatioTTM": "0.186",
    "PriceToBookRatio": "5.27",
    "EVToRevenue": "0.535",
    "EVToEBITDA": "3.119",
    "Beta": "4.433",
    "52WeekHigh": "2.45",
    "52WeekLow": "0.485",
    "50DayMovingAverage": "0.813",
    "200DayMovingAverage": "1.271",
    "SharesOutstanding": "18707600",
    "DividendDate": "2018-03-05",
    "ExDividendDate": "None"
  },
  "ANY": {
    "Symbol": "ANY",
    "AssetType": "Common Stock",
    "Name": "Sphere 3D Corp",
    "Description": "Sphere 3D Corp. The company is headquartered in Toronto, Canada.",
    "CIK": "1591956",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROCESSING & DATA PREPARATION",
    "Address": "895 DON MILLS ROAD, BLDG. 2, SUITE 900, TORONTO, ON, CA",
    "OfficialSite": "https://sphere3d.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "16035600",
    "EBITDA": "-8578000",
    "PERatio": "None",
    "PEGRatio": "-0.02",
    "BookValue": "1.712",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.76",
    "RevenuePerShareTTM": "1.228",
    "ProfitMargin": "-0.509",
    "OperatingMarginTTM": "-2.188",
    "ReturnOnAssetsTTM": "-0.19",
    "ReturnOnEquityTTM": "-0.249",
    "RevenueTTM": "21657000",
    "GrossProfitTTM": "5775000",
    "DilutedEPSTTM": "-0.76",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.589",
    "AnalystTargetPrice": "3",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.74",
    "PriceToBookRatio": "0.447",
    "EVToRevenue": "0.765",
    "EVToEBITDA": "-0.428",
    "Beta": "2.981",
    "52WeekHigh": "1.95",
    "52WeekLow": "0.595",
    "50DayMovingAverage": "0.903",
    "200DayMovingAverage": "1.034",
    "SharesOutstanding": "25453300",
    "DividendDate": "2018-11-06",
    "ExDividendDate": "None"
  },
  "INTC": {
    "Symbol": "INTC",
    "AssetType": "Common Stock",
    "Name": "Intel Corporation",
    "Description": "Intel Corporation is an American multinational corporation and technology company headquartered in Santa Clara, California, in Silicon Valley. It is the world's largest semiconductor chip manufacturer by revenue, and is the developer of the x86 series of microprocessors, the processors found in most personal computers (PCs).",
    "CIK": "50863",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "SEMICONDUCTORS & RELATED DEVICES",
    "Address": "2200 MISSION COLLEGE BLVD, RNB-4-151, SANTA CLARA, CA, US",
    "OfficialSite": "https://www.intel.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "102772548000",
    "EBITDA": "7526000000",
    "PERatio": "None",
    "PEGRatio": "0.501",
    "BookValue": "22.93",
    "DividendPerShare": "0.375",
    "DividendYield": "0.0224",
    "EPS": "-4.38",
    "RevenuePerShareTTM": "12.41",
    "ProfitMargin": "-0.353",
    "OperatingMarginTTM": "-0.185",
    "ReturnOnAssetsTTM": "-0.0123",
    "ReturnOnEquityTTM": "-0.179",
    "RevenueTTM": "53100999000",
    "GrossProfitTTM": "18224001000",
    "DilutedEPSTTM": "-4.38",
    "QuarterlyEarningsGrowthYOY": "-0.717",
    "QuarterlyRevenueGrowthYOY": "-0.074",
    "AnalystTargetPrice": "22.77",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "38",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "3",
    "TrailingPE": "-",
    "ForwardPE": "52.08",
    "PriceToSalesRatioTTM": "1.935",
    "PriceToBookRatio": "1.035",
    "EVToRevenue": "2.461",
    "EVToEBITDA": "108.64",
    "Beta": "1.074",
    "52WeekHigh": "46.15",
    "52WeekLow": "18.51",
    "50DayMovingAverage": "21.08",
    "200DayMovingAverage": "24.46",
    "SharesOutstanding": "4330000000",
    "DividendDate": "2024-09-01",
    "ExDividendDate": "2024-08-07"
  },
  "ACON": {
    "Symbol": "ACON",
    "AssetType": "Common Stock",
    "Name": "Aclarion Inc",
    "Description": "None",
    "CIK": "1635077",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SERVICES-MEDICAL LABORATORIES",
    "Address": "8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, US",
    "OfficialSite": "https://www.aclarion.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "7111200",
    "EBITDA": "-4650492",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "83.7",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-804.49",
    "RevenuePerShareTTM": "2.777",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-89.95",
    "ReturnOnAssetsTTM": "-1.277",
    "ReturnOnEquityTTM": "-7.45",
    "RevenueTTM": "49290",
    "GrossProfitTTM": "-34229",
    "DilutedEPSTTM": "-804.49",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.244",
    "AnalystTargetPrice": "435.5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "144.28",
    "PriceToBookRatio": "2.287",
    "EVToRevenue": "108.42",
    "EVToEBITDA": "-0.563",
    "Beta": "0.469",
    "52WeekHigh": "154.1",
    "52WeekLow": "2.433",
    "50DayMovingAverage": "21.3",
    "200DayMovingAverage": "63.62",
    "SharesOutstanding": "1015900",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "LXRX": {
    "Symbol": "LXRX",
    "AssetType": "Common Stock",
    "Name": "Lexicon Pharmaceuticals Inc",
    "Description": "Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.",
    "CIK": "1062822",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "8800 TECHNOLOGY FOREST PLACE, THE WOODLANDS, TX, US",
    "OfficialSite": "https://www.lexpharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "256081000",
    "EBITDA": "-210560992",
    "PERatio": "None",
    "PEGRatio": "-0.14",
    "BookValue": "0.494",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.74",
    "RevenuePerShareTTM": "0.018",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-36.4",
    "ReturnOnAssetsTTM": "-0.442",
    "ReturnOnEquityTTM": "-1.361",
    "RevenueTTM": "5229000",
    "GrossProfitTTM": "-67666000",
    "DilutedEPSTTM": "-0.74",
    "QuarterlyEarningsGrowthYOY": "-0.634",
    "QuarterlyRevenueGrowthYOY": "9.8",
    "AnalystTargetPrice": "3.6",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "48.97",
    "PriceToBookRatio": "1.417",
    "EVToRevenue": "18.3",
    "EVToEBITDA": "-2.576",
    "Beta": "1.047",
    "52WeekHigh": "2.829",
    "52WeekLow": "0.62",
    "50DayMovingAverage": "0.767",
    "200DayMovingAverage": "1.402",
    "SharesOutstanding": "361492000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "CLRO": {
    "Symbol": "CLRO",
    "AssetType": "Common Stock",
    "Name": "ClearOne Inc",
    "Description": "ClearOne, Inc. designs, develops, and sells conferencing, collaboration, and network transmission solutions for voice and visual communications in the United States and internationally. The company is headquartered in Salt Lake City, Utah.",
    "CIK": "840715",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "TELEPHONE & TELEGRAPH APPARATUS",
    "Address": "5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY, UT, US",
    "OfficialSite": "https://www.clearone.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "12392000",
    "EBITDA": "-8227000",
    "PERatio": "None",
    "PEGRatio": "4.74",
    "BookValue": "0.98",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "-0.17",
    "RevenuePerShareTTM": "0.525",
    "ProfitMargin": "-0.329",
    "OperatingMarginTTM": "-0.874",
    "ReturnOnAssetsTTM": "-0.14",
    "ReturnOnEquityTTM": "-0.126",
    "RevenueTTM": "12584000",
    "GrossProfitTTM": "3602000",
    "DilutedEPSTTM": "-0.17",
    "QuarterlyEarningsGrowthYOY": "-0.87",
    "QuarterlyRevenueGrowthYOY": "-0.488",
    "AnalystTargetPrice": "4.05",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.985",
    "PriceToBookRatio": "0.51",
    "EVToRevenue": "0.766",
    "EVToEBITDA": "-18.81",
    "Beta": "0.706",
    "52WeekHigh": "1.7",
    "52WeekLow": "0.45",
    "50DayMovingAverage": "0.614",
    "200DayMovingAverage": "0.63",
    "SharesOutstanding": "23969100",
    "DividendDate": "2024-04-10",
    "ExDividendDate": "2024-04-11"
  },
  "NIVF": {
    "Symbol": "NIVF",
    "AssetType": "Common Stock",
    "Name": "NewGenIvf Group Limited Class A Ordinary Shares",
    "Description": "None",
    "CIK": "1981662",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SERVICES-MISC HEALTH & ALLIED SERVICES, NEC",
    "Address": "36/39-36/40, 13TH FLOOR, PS TOWERSUKHUMV, KHLONG TOEI NUEA SUB-DISTRICT, BANGKOK, TH",
    "OfficialSite": "https://newgenivf.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "7090400",
    "EBITDA": "None",
    "PERatio": "69.86",
    "PEGRatio": "None",
    "BookValue": "None",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "None",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "0",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "69.86",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.381",
    "PriceToBookRatio": "7.91",
    "EVToRevenue": "1.435",
    "EVToEBITDA": "19.17",
    "Beta": "None",
    "52WeekHigh": "344.8",
    "52WeekLow": "1.85",
    "50DayMovingAverage": "0.89",
    "200DayMovingAverage": "5.23",
    "SharesOutstanding": "0",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "PNBK": {
    "Symbol": "PNBK",
    "AssetType": "Common Stock",
    "Name": "Patriot National Bancorp Inc",
    "Description": "Patriot National Bancorp, Inc. is the parent company of Patriot Bank, NA providing community banking services to individuals, small and medium-sized businesses, and professionals. ",
    "CIK": "1098146",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "FINANCE",
    "Industry": "NATIONAL COMMERCIAL BANKS",
    "Address": "900 BEDFORD ST, STAMFORD, CT, US",
    "OfficialSite": "https://bankpatriot.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "4333900",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "4.121",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-7.4",
    "RevenuePerShareTTM": "6.87",
    "ProfitMargin": "-1.078",
    "OperatingMarginTTM": "-0.316",
    "ReturnOnAssetsTTM": "-0.0279",
    "ReturnOnEquityTTM": "-1.044",
    "RevenueTTM": "27300000",
    "GrossProfitTTM": "27300000",
    "DilutedEPSTTM": "-7.4",
    "QuarterlyEarningsGrowthYOY": "-0.48",
    "QuarterlyRevenueGrowthYOY": "1.025",
    "AnalystTargetPrice": "24",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.159",
    "PriceToBookRatio": "0.264",
    "EVToRevenue": "4.122",
    "EVToEBITDA": "-",
    "Beta": "0.437",
    "52WeekHigh": "4.05",
    "52WeekLow": "0.99",
    "50DayMovingAverage": "1.677",
    "200DayMovingAverage": "1.873",
    "SharesOutstanding": "3976100",
    "DividendDate": "2019-12-19",
    "ExDividendDate": "2019-12-06"
  },
  "TRAW": {
    "Symbol": "TRAW",
    "AssetType": "Common Stock",
    "Name": "Traws Pharma Inc",
    "Description": "Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania.",
    "CIK": "1130598",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "375 PHEASANT RUN, NEWTOWN, PA, US",
    "OfficialSite": "https://www.trawspharma.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "12083900",
    "EBITDA": "-24080000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-0.672",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-135.78",
    "RevenuePerShareTTM": "0.228",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-149.75",
    "ReturnOnAssetsTTM": "-0.837",
    "ReturnOnEquityTTM": "-22.55",
    "RevenueTTM": "226000",
    "GrossProfitTTM": "226000",
    "DilutedEPSTTM": "-135.78",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "6.5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "53.47",
    "PriceToBookRatio": "1.675",
    "EVToRevenue": "29.53",
    "EVToEBITDA": "0.329",
    "Beta": "1.105",
    "52WeekHigh": "27.5",
    "52WeekLow": "3.06",
    "50DayMovingAverage": "6.95",
    "200DayMovingAverage": "8.36",
    "SharesOutstanding": "3650700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "DHAI": {
    "Symbol": "DHAI",
    "AssetType": "Common Stock",
    "Name": "DIH Holdings US, Inc. Class A Common Stock",
    "Description": "DIH Holding US, Inc. is a robotics and virtual reality technology provider in the rehabilitation and human performance industry. The company is headquartered in Norwell, Massachusetts.",
    "CIK": "1883788",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "BLANK CHECKS",
    "Address": "4 EMBARCADERO CENTER SUITE 1449, SAN FRANCISCO, CA, US",
    "OfficialSite": "https://www.dih.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "23019600",
    "EBITDA": "-2074000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-1.087",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.32",
    "RevenuePerShareTTM": "2.073",
    "ProfitMargin": "-0.148",
    "OperatingMarginTTM": "-0.175",
    "ReturnOnAssetsTTM": "-0.0463",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "69573000",
    "GrossProfitTTM": "34814000",
    "DilutedEPSTTM": "-0.32",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.206",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.331",
    "PriceToBookRatio": "3.03",
    "EVToRevenue": "0.573",
    "EVToEBITDA": "-",
    "Beta": "-0.658",
    "52WeekHigh": "3.67",
    "52WeekLow": "0.35",
    "50DayMovingAverage": "1.034",
    "200DayMovingAverage": "1.812",
    "SharesOutstanding": "47336300",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "OCFT": {
    "Symbol": "OCFT",
    "AssetType": "Common Stock",
    "Name": "Oneconnect Financial Technology Co",
    "Description": "OneConnect Financial Technology Co., Ltd. provides cloud platform-based Fintech solutions and online information and operational support services for financial institutions in the People's Republic of China. ",
    "CIK": "1780531",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.",
    "Address": "21/24F, PING AN FINANCE CENTER, NO. 5033 YITIAN ROAD FUTIAN DISTRICT, SHENZHEN, GUANGDONG, CHINA",
    "OfficialSite": "https://www.ocft.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "114353000",
    "EBITDA": "-343321984",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "2.687",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.18",
    "RevenuePerShareTTM": "2.983",
    "ProfitMargin": "-0.0102",
    "OperatingMarginTTM": "-0.0672",
    "ReturnOnAssetsTTM": "-0.0338",
    "ReturnOnEquityTTM": "-0.106",
    "RevenueTTM": "3250292000",
    "GrossProfitTTM": "1635016000",
    "DilutedEPSTTM": "-1.18",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.263",
    "AnalystTargetPrice": "2.26",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "81.3",
    "PriceToSalesRatioTTM": "0.0889",
    "PriceToBookRatio": "0.506",
    "EVToRevenue": "0.0022",
    "EVToEBITDA": "0.17",
    "Beta": "1.845",
    "52WeekHigh": "5.68",
    "52WeekLow": "0.865",
    "50DayMovingAverage": "2.157",
    "200DayMovingAverage": "2.003",
    "SharesOutstanding": "38999400",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "AMPX": {
    "Symbol": "AMPX",
    "AssetType": "Common Stock",
    "Name": "Amprius Technologies Inc.",
    "Description": "Amprius Technologies, Inc. manufactures and distributes lithium ion batteries. The company is headquartered in Fremont, California.",
    "CIK": "1899287",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES",
    "Address": "1180 PAGE AVENUE, FREMONT, CA, US",
    "OfficialSite": "https://amprius.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "281966000",
    "EBITDA": "-40843000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.503",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.45",
    "RevenuePerShareTTM": "0.181",
    "ProfitMargin": "-2.459",
    "OperatingMarginTTM": "-1.433",
    "ReturnOnAssetsTTM": "-0.29",
    "ReturnOnEquityTTM": "-0.706",
    "RevenueTTM": "17480000",
    "GrossProfitTTM": "-19956000",
    "DilutedEPSTTM": "-0.45",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "1.807",
    "AnalystTargetPrice": "8.43",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "5",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "16.13",
    "PriceToBookRatio": "5.04",
    "EVToRevenue": "16.5",
    "EVToEBITDA": "-34.49",
    "Beta": "2.465",
    "52WeekHigh": "4.205",
    "52WeekLow": "0.613",
    "50DayMovingAverage": "2.997",
    "200DayMovingAverage": "1.764",
    "SharesOutstanding": "110575000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "GOVX": {
    "Symbol": "GOVX",
    "AssetType": "Common Stock",
    "Name": "GeoVax Labs Inc",
    "Description": "GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.",
    "CIK": "832489",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1900 LAKE PARK DRIVE, SUITE 380, SMYRNA, GE",
    "OfficialSite": "https://www.geovax.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "13587900",
    "EBITDA": "-24397688",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.988",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-8.39",
    "RevenuePerShareTTM": "0.945",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-2.099",
    "ReturnOnAssetsTTM": "-1.121",
    "ReturnOnEquityTTM": "-2.76",
    "RevenueTTM": "3090200",
    "GrossProfitTTM": "-19249188",
    "DilutedEPSTTM": "-8.39",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-1",
    "AnalystTargetPrice": "14.6",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "10.63",
    "PriceToSalesRatioTTM": "4.397",
    "PriceToBookRatio": "1.598",
    "EVToRevenue": "3.938",
    "EVToEBITDA": "0.103",
    "Beta": "3.286",
    "52WeekHigh": "11.18",
    "52WeekLow": "1.09",
    "50DayMovingAverage": "2.007",
    "200DayMovingAverage": "2.496",
    "SharesOutstanding": "9436100",
    "DividendDate": "2020-09-25",
    "ExDividendDate": "None"
  },
  "BBAI": {
    "Symbol": "BBAI",
    "AssetType": "Common Stock",
    "Name": "BigBearai Holdings Inc",
    "Description": "None",
    "CIK": "1836981",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-PREPACKAGED SOFTWARE",
    "Address": "6811 BENJAMIN FRANKLIN DRIVE, SUITE 200, COLUMBIA, MD, US",
    "OfficialSite": "https://bigbear.ai",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "1197397000",
    "EBITDA": "-29966000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.394",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.78",
    "RevenuePerShareTTM": "0.737",
    "ProfitMargin": "-1.099",
    "OperatingMarginTTM": "-0.198",
    "ReturnOnAssetsTTM": "-0.0913",
    "ReturnOnEquityTTM": "-7.38",
    "RevenueTTM": "154972000",
    "GrossProfitTTM": "41831000",
    "DilutedEPSTTM": "-0.78",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.221",
    "AnalystTargetPrice": "4.75",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "7.73",
    "PriceToBookRatio": "13.19",
    "EVToRevenue": "9.28",
    "EVToEBITDA": "-3.258",
    "Beta": "2.869",
    "52WeekHigh": "10.36",
    "52WeekLow": "1.165",
    "50DayMovingAverage": "5.06",
    "200DayMovingAverage": "2.499",
    "SharesOutstanding": "251554000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "ALLR": {
    "Symbol": "ALLR",
    "AssetType": "Common Stock",
    "Name": "Allarity Therapeutics Inc",
    "Description": "Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark.",
    "CIK": "1860657",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US",
    "OfficialSite": "https://www.allarity.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "2062500",
    "EBITDA": "-16895000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "16.98",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-10.98",
    "RevenuePerShareTTM": "-0.018",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.477",
    "ReturnOnEquityTTM": "-1.218",
    "RevenueTTM": "-7127000",
    "GrossProfitTTM": "-36348000",
    "DilutedEPSTTM": "-10.98",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "0.307",
    "EVToRevenue": "-",
    "EVToEBITDA": "-0.0842",
    "Beta": "0.291",
    "52WeekHigh": "250.8",
    "52WeekLow": "0.677",
    "50DayMovingAverage": "2.206",
    "200DayMovingAverage": "64.88",
    "SharesOutstanding": "1412600",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "PLRX": {
    "Symbol": "PLRX",
    "AssetType": "Common Stock",
    "Name": "Pliant Therapeutics Inc",
    "Description": "Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and markets new therapies for the treatment of fibrosis and related diseases in the United States. The company is headquartered in South San Francisco, California.",
    "CIK": "1746473",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA, US",
    "OfficialSite": "https://pliantrx.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "83978000",
    "EBITDA": "-219951008",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "5.68",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-3.35",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.281",
    "ReturnOnEquityTTM": "-0.475",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-3.35",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-1",
    "AnalystTargetPrice": "16.14",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "7",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "3050.34",
    "PriceToBookRatio": "0.605",
    "EVToRevenue": "1376.69",
    "EVToEBITDA": "-2.537",
    "Beta": "1.186",
    "52WeekHigh": "16.52",
    "52WeekLow": "1.37",
    "50DayMovingAverage": "9.62",
    "200DayMovingAverage": "12.08",
    "SharesOutstanding": "60854000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "ONON": {
    "Symbol": "ONON",
    "AssetType": "Common Stock",
    "Name": "On Holding Ltd",
    "Description": "On Holding AG develops and distributes sports products worldwide. The company is headquartered in Zurich, Switzerland.",
    "CIK": "1858985",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "RUBBER & PLASTICS FOOTWEAR",
    "Address": "PFINGSTWEIDSTRASSE 106, 8005 ZURICH, CH",
    "OfficialSite": "https://www.on-running.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "15470048000",
    "EBITDA": "256700000",
    "PERatio": "108.75",
    "PEGRatio": "None",
    "BookValue": "3.915",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.44",
    "RevenuePerShareTTM": "6.71",
    "ProfitMargin": "0.0584",
    "OperatingMarginTTM": "0.114",
    "ReturnOnAssetsTTM": "0.0652",
    "ReturnOnEquityTTM": "0.107",
    "RevenueTTM": "2158800000",
    "GrossProfitTTM": "1299100000",
    "DilutedEPSTTM": "0.44",
    "QuarterlyEarningsGrowthYOY": "-0.487",
    "QuarterlyRevenueGrowthYOY": "0.323",
    "AnalystTargetPrice": "63.53",
    "AnalystRatingStrongBuy": "7",
    "AnalystRatingBuy": "16",
    "AnalystRatingHold": "4",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "108.75",
    "ForwardPE": "42.55",
    "PriceToSalesRatioTTM": "7.17",
    "PriceToBookRatio": "11.08",
    "EVToRevenue": "6.37",
    "EVToEBITDA": "53.58",
    "Beta": "2.349",
    "52WeekHigh": "64.05",
    "52WeekLow": "27.37",
    "50DayMovingAverage": "55.7",
    "200DayMovingAverage": "48.13",
    "SharesOutstanding": "288760000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "ESPR": {
    "Symbol": "ESPR",
    "AssetType": "Common Stock",
    "Name": "Esperion Therapeutics Inc",
    "Description": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan.",
    "CIK": "1434868",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US",
    "OfficialSite": "https://www.esperion.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "311315000",
    "EBITDA": "16497000",
    "PERatio": "None",
    "PEGRatio": "-4.78",
    "BookValue": "-1.894",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.67",
    "RevenuePerShareTTM": "1.776",
    "ProfitMargin": "-0.294",
    "OperatingMarginTTM": "-0.31",
    "ReturnOnAssetsTTM": "0.0384",
    "ReturnOnEquityTTM": "-2.608",
    "RevenueTTM": "295451000",
    "GrossProfitTTM": "188026000",
    "DilutedEPSTTM": "-0.67",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.52",
    "AnalystTargetPrice": "6.76",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "3",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "-",
    "ForwardPE": "1.345",
    "PriceToSalesRatioTTM": "1.054",
    "PriceToBookRatio": "98.42",
    "EVToRevenue": "1.551",
    "EVToEBITDA": "-3.863",
    "Beta": "1.042",
    "52WeekHigh": "3.94",
    "52WeekLow": "1.57",
    "50DayMovingAverage": "2.035",
    "200DayMovingAverage": "2.176",
    "SharesOutstanding": "197035000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "XCUR": {
    "Symbol": "XCUR",
    "AssetType": "Common Stock",
    "Name": "Exicure Inc",
    "Description": "Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. The company is headquartered in Chicago, Illinois.",
    "CIK": "1698530",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "8045 LAMON AVE, SUITE 410, SKOKIE, IL, US",
    "OfficialSite": "https://www.exicuretx.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "34401800",
    "EBITDA": "-4975000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.711",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.04",
    "RevenuePerShareTTM": "0.274",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-10.01",
    "ReturnOnAssetsTTM": "-0.265",
    "ReturnOnEquityTTM": "-1.326",
    "RevenueTTM": "500000",
    "GrossProfitTTM": "-769000",
    "DilutedEPSTTM": "-2.04",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "9.28",
    "AnalystTargetPrice": "2",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "68.8",
    "PriceToBookRatio": "18.39",
    "EVToRevenue": "68.4",
    "EVToEBITDA": "-0.042",
    "Beta": "3.851",
    "52WeekHigh": "36",
    "52WeekLow": "1.44",
    "50DayMovingAverage": "11.76",
    "200DayMovingAverage": "6.27",
    "SharesOutstanding": "3039000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "WW": {
    "Symbol": "WW",
    "AssetType": "Common Stock",
    "Name": "WW International Inc",
    "Description": "WW International, Inc. offers worldwide weight management products and services. The company is headquartered in New York, New York.",
    "CIK": "105319",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-PERSONAL SERVICES",
    "Address": "675 AVENUE OF THE AMERICAS, 6TH FLOOR, NEW YORK, NY, US",
    "OfficialSite": "https://corporate.ww.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "37216400",
    "EBITDA": "121717000",
    "PERatio": "None",
    "PEGRatio": "4.921",
    "BookValue": "-13.92",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-4.34",
    "RevenuePerShareTTM": "9.88",
    "ProfitMargin": "-0.44",
    "OperatingMarginTTM": "0.0866",
    "ReturnOnAssetsTTM": "0.0685",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "785921000",
    "GrossProfitTTM": "535613000",
    "DilutedEPSTTM": "-4.34",
    "QuarterlyEarningsGrowthYOY": "-0.554",
    "QuarterlyRevenueGrowthYOY": "-0.105",
    "AnalystTargetPrice": "1",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "3",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "212.77",
    "PriceToSalesRatioTTM": "0.0474",
    "PriceToBookRatio": "-",
    "EVToRevenue": "1.885",
    "EVToEBITDA": "-7.12",
    "Beta": "1.84",
    "52WeekHigh": "3.25",
    "52WeekLow": "0.44",
    "50DayMovingAverage": "1.116",
    "200DayMovingAverage": "1.153",
    "SharesOutstanding": "79864000",
    "DividendDate": "2013-10-11",
    "ExDividendDate": "2013-09-25"
  },
  "BDSX": {
    "Symbol": "BDSX",
    "AssetType": "Common Stock",
    "Name": "Biodesix Inc",
    "Description": "Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.",
    "CIK": "1439725",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SERVICES-MEDICAL LABORATORIES",
    "Address": "2970 WILDERNESS PLACE, SUITE 100, BOULDER, CO, US",
    "OfficialSite": "https://www.biodesix.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "103718000",
    "EBITDA": "-29259000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.192",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.37",
    "RevenuePerShareTTM": "0.566",
    "ProfitMargin": "-0.668",
    "OperatingMarginTTM": "-0.473",
    "ReturnOnAssetsTTM": "-0.228",
    "ReturnOnEquityTTM": "-3.318",
    "RevenueTTM": "65562000",
    "GrossProfitTTM": "50957000",
    "DilutedEPSTTM": "-0.37",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.345",
    "AnalystTargetPrice": "3.1",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "5",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.582",
    "PriceToBookRatio": "4.141",
    "EVToRevenue": "2.225",
    "EVToEBITDA": "-2.719",
    "Beta": "1.096",
    "52WeekHigh": "2.04",
    "52WeekLow": "0.7",
    "50DayMovingAverage": "1.144",
    "200DayMovingAverage": "1.475",
    "SharesOutstanding": "145467000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SE": {
    "Symbol": "SE",
    "AssetType": "Common Stock",
    "Name": "Sea Ltd",
    "Description": "Sea Limited is engaged in the digital entertainment, e-commerce and digital financial services businesses in Southeast Asia, Latin America, the rest of Asia and internationally. The company is headquartered in Singapore.",
    "CIK": "1703399",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-MISCELLANEOUS BUSINESS SERVICES",
    "Address": "C/O 1 FUSIONOPOLIS PLACE, # 17-10, GALAXIS, SINGAPORE, SG",
    "OfficialSite": "https://www.sea.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "70925238000",
    "EBITDA": "750103000",
    "PERatio": "823.27",
    "PEGRatio": "0.685",
    "BookValue": "13.42",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.15",
    "RevenuePerShareTTM": "27.06",
    "ProfitMargin": "0.0063",
    "OperatingMarginTTM": "0.0468",
    "ReturnOnAssetsTTM": "0.0094",
    "ReturnOnEquityTTM": "0.0135",
    "RevenueTTM": "15486058000",
    "GrossProfitTTM": "6524415000",
    "DilutedEPSTTM": "0.15",
    "QuarterlyEarningsGrowthYOY": "-0.741",
    "QuarterlyRevenueGrowthYOY": "0.308",
    "AnalystTargetPrice": "133.55",
    "AnalystRatingStrongBuy": "8",
    "AnalystRatingBuy": "19",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "823.27",
    "ForwardPE": "51.02",
    "PriceToSalesRatioTTM": "4.58",
    "PriceToBookRatio": "9.23",
    "EVToRevenue": "4.494",
    "EVToEBITDA": "151.56",
    "Beta": "1.617",
    "52WeekHigh": "139.18",
    "52WeekLow": "51.7",
    "50DayMovingAverage": "118.45",
    "200DayMovingAverage": "93.2",
    "SharesOutstanding": "528812000",
    "DividendDate": "2017-03-01",
    "ExDividendDate": "None"
  },
  "TGT": {
    "Symbol": "TGT",
    "AssetType": "Common Stock",
    "Name": "Target Corporation",
    "Description": "Target Corporation is an American retail corporation. Their retail formats include the discount store Target, the hypermarket SuperTarget, and small-format stores previously named CityTarget and TargetExpress before being consolidated under the Target branding.",
    "CIK": "27419",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "RETAIL-VARIETY STORES",
    "Address": "1000 NICOLLET MALL, MINNEAPOLIS, MN, US",
    "OfficialSite": "https://corporate.target.com",
    "FiscalYearEnd": "January",
    "LatestQuarter": "2024-10-31",
    "MarketCapitalization": "55333683000",
    "EBITDA": "9053000000",
    "PERatio": "12.81",
    "PEGRatio": "1.723",
    "BookValue": "31.55",
    "DividendPerShare": "4.42",
    "DividendYield": "0.0361",
    "EPS": "9.43",
    "RevenuePerShareTTM": "233.01",
    "ProfitMargin": "0.0406",
    "OperatingMarginTTM": "0.0466",
    "ReturnOnAssetsTTM": "0.0665",
    "ReturnOnEquityTTM": "0.324",
    "RevenueTTM": "107570004000",
    "GrossProfitTTM": "30543999000",
    "DilutedEPSTTM": "9.43",
    "QuarterlyEarningsGrowthYOY": "-0.119",
    "QuarterlyRevenueGrowthYOY": "0.011",
    "AnalystTargetPrice": "143.83",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "11",
    "AnalystRatingHold": "22",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "12.81",
    "ForwardPE": "13.07",
    "PriceToSalesRatioTTM": "0.514",
    "PriceToBookRatio": "3.929",
    "EVToRevenue": "0.678",
    "EVToEBITDA": "8.09",
    "Beta": "1.182",
    "52WeekHigh": "176.42",
    "52WeekLow": "119.19",
    "50DayMovingAverage": "133.54",
    "200DayMovingAverage": "144.24",
    "SharesOutstanding": "458212000",
    "DividendDate": "2025-03-01",
    "ExDividendDate": "2025-02-12"
  },
  "ABTS": {
    "Symbol": "ABTS",
    "AssetType": "Common Stock",
    "Name": "Abits Group Inc.",
    "Description": "Abits Group Inc. provides bitcoin mining and related services in the United States. The company is headquartered in Beijing, the People's Republic of China.",
    "CIK": "1864055",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER PROCESSING & DATA PREPARATION",
    "Address": "UNIT 911, TOWER 2, SILVERCORD,, 30 CANTON ROAD, TSIMSHATSUI, HONG KONG SAR, CHINA",
    "OfficialSite": "https://www.abitsgroup.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2023-12-31",
    "MarketCapitalization": "14755200",
    "EBITDA": "1366500",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.317",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.26",
    "RevenuePerShareTTM": "0.15",
    "ProfitMargin": "-1.702",
    "OperatingMarginTTM": "-0.0971",
    "ReturnOnAssetsTTM": "-0.0777",
    "ReturnOnEquityTTM": "-0.573",
    "RevenueTTM": "5343900",
    "GrossProfitTTM": "1786000",
    "DilutedEPSTTM": "-0.26",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "503.62",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "2.761",
    "PriceToBookRatio": "1.312",
    "EVToRevenue": "2.695",
    "EVToEBITDA": "-19.39",
    "Beta": "2.652",
    "52WeekHigh": "1",
    "52WeekLow": "0.376",
    "50DayMovingAverage": "0.478",
    "200DayMovingAverage": "0.528",
    "SharesOutstanding": "35554700",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "AACG": {
    "Symbol": "AACG",
    "AssetType": "Common Stock",
    "Name": "ATA Creativity Global",
    "Description": "ATA Creativity Global, provides educational services to individual students through its network of training centers in China. The company is headquartered in Beijing, China.",
    "CIK": "1420529",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "China",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-EDUCATIONAL SERVICES",
    "Address": "8TH FLOOR, TOWER E, 6 GONGYUAN WEST ST., JIAN GUO MEN NEI, BEIJING, CHINA",
    "OfficialSite": "https://ir.atai.net.cn/",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "23605400",
    "EBITDA": "-29397596",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "2.104",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.18",
    "RevenuePerShareTTM": "7.96",
    "ProfitMargin": "-0.163",
    "OperatingMarginTTM": "-0.262",
    "ReturnOnAssetsTTM": "-0.0688",
    "ReturnOnEquityTTM": "-0.481",
    "RevenueTTM": "250753000",
    "GrossProfitTTM": "129967000",
    "DilutedEPSTTM": "-0.18",
    "QuarterlyEarningsGrowthYOY": "3.119",
    "QuarterlyRevenueGrowthYOY": "0.131",
    "AnalystTargetPrice": "11",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.0941",
    "PriceToBookRatio": "2.86",
    "EVToRevenue": "0.76",
    "EVToEBITDA": "-1.227",
    "Beta": "0.783",
    "52WeekHigh": "1.65",
    "52WeekLow": "0.5",
    "50DayMovingAverage": "0.873",
    "200DayMovingAverage": "0.825",
    "SharesOutstanding": "31473900",
    "DividendDate": "2018-08-24",
    "ExDividendDate": "2018-08-27"
  },
  "AEMD": {
    "Symbol": "AEMD",
    "AssetType": "Common Stock",
    "Name": "Aethlon Medical Inc",
    "Description": "Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.",
    "CIK": "882291",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
    "Address": "9635 GRANITE RIDGE DRIVE, SUITE 100, SAN DIEGO, CA, US",
    "OfficialSite": "https://www.aethlonmedical.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "6504200",
    "EBITDA": "-9492618",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.31",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.58",
    "RevenuePerShareTTM": "0.236",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.725",
    "ReturnOnEquityTTM": "-1.6",
    "RevenueTTM": "574240",
    "GrossProfitTTM": "574240",
    "DilutedEPSTTM": "-1.58",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "42.78",
    "AnalystTargetPrice": "3.875",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "0.21",
    "PriceToSalesRatioTTM": "2.373",
    "PriceToBookRatio": "1.666",
    "EVToRevenue": "1.066",
    "EVToEBITDA": "0.244",
    "Beta": "1.81",
    "52WeekHigh": "1.85",
    "52WeekLow": "0.237",
    "50DayMovingAverage": "0.648",
    "200DayMovingAverage": "0.482",
    "SharesOutstanding": "14457100",
    "DividendDate": "2019-10-15",
    "ExDividendDate": "None"
  },
  "OLPX": {
    "Symbol": "OLPX",
    "AssetType": "Common Stock",
    "Name": "Olaplex Holdings Inc",
    "Description": "None",
    "CIK": "1868726",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS",
    "Address": "1187 COAST VILLAGE ROAD, SUITE 1-520, SANTA BARBARA, CA, US",
    "OfficialSite": "https://www.olaplex.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "914834000",
    "EBITDA": "140117000",
    "PERatio": "23",
    "PEGRatio": "None",
    "BookValue": "1.328",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.06",
    "RevenuePerShareTTM": "0.656",
    "ProfitMargin": "0.0978",
    "OperatingMarginTTM": "0.235",
    "ReturnOnAssetsTTM": "0.032",
    "ReturnOnEquityTTM": "0.0493",
    "RevenueTTM": "433646000",
    "GrossProfitTTM": "311393000",
    "DilutedEPSTTM": "0.06",
    "QuarterlyEarningsGrowthYOY": "-0.333",
    "QuarterlyRevenueGrowthYOY": "-0.036",
    "AnalystTargetPrice": "2.119",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "0",
    "AnalystRatingHold": "9",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "23",
    "ForwardPE": "16.1",
    "PriceToSalesRatioTTM": "2.11",
    "PriceToBookRatio": "1.093",
    "EVToRevenue": "2.477",
    "EVToEBITDA": "6.42",
    "Beta": "2.441",
    "52WeekHigh": "2.77",
    "52WeekLow": "1.19",
    "50DayMovingAverage": "1.592",
    "200DayMovingAverage": "1.858",
    "SharesOutstanding": "662923000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SCPH": {
    "Symbol": "SCPH",
    "AssetType": "Common Stock",
    "Name": "Scpharmaceuticals Inc",
    "Description": "scPharmaceuticals Inc., a pharmaceutical company, is engaged in the development and commercialization of various pharmaceutical products. The company is headquartered in Burlington, Massachusetts.",
    "CIK": "1604950",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "2400 DISTRICT AVENUE, SUITE 310, BURLINGTON, MA, US",
    "OfficialSite": "https://www.scpharmaceuticals.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "160629000",
    "EBITDA": "-63668000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.614",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.95",
    "RevenuePerShareTTM": "0.741",
    "ProfitMargin": "-2.646",
    "OperatingMarginTTM": "-1.81",
    "ReturnOnAssetsTTM": "-0.344",
    "ReturnOnEquityTTM": "-2.006",
    "RevenueTTM": "30278000",
    "GrossProfitTTM": "21109000",
    "DilutedEPSTTM": "-1.95",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "1.641",
    "AnalystTargetPrice": "17.5",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "5.31",
    "PriceToBookRatio": "5.34",
    "EVToRevenue": "4.133",
    "EVToEBITDA": "-6.69",
    "Beta": "0.394",
    "52WeekHigh": "6.2",
    "52WeekLow": "3.075",
    "50DayMovingAverage": "3.379",
    "200DayMovingAverage": "4.108",
    "SharesOutstanding": "50040000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "PACB": {
    "Symbol": "PACB",
    "AssetType": "Common Stock",
    "Name": "Pacific Biosciences of California",
    "Description": "Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to solve genetically complex problems. The company is headquartered in Menlo Park, California.",
    "CIK": "1299130",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
    "Address": "1305 O'BRIEN DRIVE, MENLO PARK, CA, US",
    "OfficialSite": "https://www.pacb.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "387024000",
    "EBITDA": "-248676352",
    "PERatio": "None",
    "PEGRatio": "-0.17",
    "BookValue": "1.794",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.58",
    "RevenuePerShareTTM": "0.561",
    "ProfitMargin": "-2.004",
    "OperatingMarginTTM": "-1.623",
    "ReturnOnAssetsTTM": "-0.121",
    "ReturnOnEquityTTM": "-0.511",
    "RevenueTTM": "154014000",
    "GrossProfitTTM": "47673000",
    "DilutedEPSTTM": "-1.58",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.328",
    "AnalystTargetPrice": "2.667",
    "AnalystRatingStrongBuy": "1",
    "AnalystRatingBuy": "6",
    "AnalystRatingHold": "8",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "2.513",
    "PriceToBookRatio": "0.84",
    "EVToRevenue": "4.605",
    "EVToEBITDA": "-4.154",
    "Beta": "1.859",
    "52WeekHigh": "5.01",
    "52WeekLow": "1.16",
    "50DayMovingAverage": "1.726",
    "200DayMovingAverage": "1.775",
    "SharesOutstanding": "294315000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BBY": {
    "Symbol": "BBY",
    "AssetType": "Common Stock",
    "Name": "Best Buy Co. Inc",
    "Description": "Best Buy Co., Inc. is an American multinational consumer electronics retailer headquartered in Richfield, Minnesota.",
    "CIK": "764478",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "RETAIL-RADIO, TV & CONSUMER ELECTRONICS STORES",
    "Address": "7601 PENN AVE SOUTH, RICHFIELD, MN, US",
    "OfficialSite": "https://corporate.bestbuy.com",
    "FiscalYearEnd": "January",
    "LatestQuarter": "2024-10-31",
    "MarketCapitalization": "18544665000",
    "EBITDA": "2650000000",
    "PERatio": "14.85",
    "PEGRatio": "1.839",
    "BookValue": "14.41",
    "DividendPerShare": "3.74",
    "DividendYield": "0.0418",
    "EPS": "5.84",
    "RevenuePerShareTTM": "195.78",
    "ProfitMargin": "0.0301",
    "OperatingMarginTTM": "0.0366",
    "ReturnOnAssetsTTM": "0.0656",
    "ReturnOnEquityTTM": "0.431",
    "RevenueTTM": "42226000000",
    "GrossProfitTTM": "9468000000",
    "DilutedEPSTTM": "5.84",
    "QuarterlyEarningsGrowthYOY": "0.043",
    "QuarterlyRevenueGrowthYOY": "-0.032",
    "AnalystTargetPrice": "97.76",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "8",
    "AnalystRatingHold": "18",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "1",
    "TrailingPE": "14.85",
    "ForwardPE": "13.89",
    "PriceToSalesRatioTTM": "0.439",
    "PriceToBookRatio": "6.24",
    "EVToRevenue": "0.536",
    "EVToEBITDA": "8.78",
    "Beta": "1.452",
    "52WeekHigh": "102.38",
    "52WeekLow": "67.21",
    "50DayMovingAverage": "86.47",
    "200DayMovingAverage": "88.44",
    "SharesOutstanding": "213796000",
    "DividendDate": "2025-01-07",
    "ExDividendDate": "2024-12-17"
  },
  "CALC": {
    "Symbol": "CALC",
    "AssetType": "Common Stock",
    "Name": "CalciMedica, Inc. Common Stock",
    "Description": "None",
    "CIK": "1534133",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "275 SHORELINE DRIVE, SUITE 450, REDWOOD CITY, CA, US",
    "OfficialSite": "https://www.calcimedica.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "29660200",
    "EBITDA": "-22288000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.839",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.13",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-0.872",
    "ReturnOnEquityTTM": "-1.283",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-1.13",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "16",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "3.254",
    "EVToRevenue": "-",
    "EVToEBITDA": "-0.256",
    "Beta": "None",
    "52WeekHigh": "6.26",
    "52WeekLow": "2.05",
    "50DayMovingAverage": "2.765",
    "200DayMovingAverage": "3.912",
    "SharesOutstanding": "13481900",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "THAR": {
    "Symbol": "THAR",
    "AssetType": "Common Stock",
    "Name": "Tharimmune Inc.",
    "Description": "None",
    "CIK": "1861657",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1200 ROUTE 22 EAST, BRIDGEWATER, NJ, US",
    "OfficialSite": "https://www.tharimmune.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "2803900",
    "EBITDA": "None",
    "PERatio": "0.0233",
    "PEGRatio": "None",
    "BookValue": "2.35",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "62.32",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "-1.651",
    "ReturnOnEquityTTM": "-4.545",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "62.32",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "5",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "0.0233",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "-",
    "PriceToBookRatio": "0.897",
    "EVToRevenue": "-",
    "EVToEBITDA": "-6.32",
    "Beta": "1.304",
    "52WeekHigh": "7.46",
    "52WeekLow": "1.35",
    "50DayMovingAverage": "1.972",
    "200DayMovingAverage": "2.8",
    "SharesOutstanding": "1933800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "WLGS": {
    "Symbol": "WLGS",
    "AssetType": "Common Stock",
    "Name": "Wang & Lee Group, Inc. Ordinary Shares",
    "Description": "None",
    "CIK": "1899658",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "CONSTRUCTION - SPECIAL TRADE CONTRACTORS",
    "Address": "5-6/F WING TAI FACTORY BUILDING, 3 TAI YIP STREET, KWUN TONG, HK",
    "OfficialSite": "https://www.wangnlee.com.hk",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "91997000",
    "EBITDA": "137250",
    "PERatio": "265",
    "PEGRatio": "None",
    "BookValue": "0.35",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.02",
    "RevenuePerShareTTM": "0.509",
    "ProfitMargin": "0.0345",
    "OperatingMarginTTM": "-0.395",
    "ReturnOnAssetsTTM": "0.0077",
    "ReturnOnEquityTTM": "0.0505",
    "RevenueTTM": "7272900",
    "GrossProfitTTM": "2133600",
    "DilutedEPSTTM": "0.02",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.311",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "265",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "12.65",
    "PriceToBookRatio": "19.71",
    "EVToRevenue": "14.01",
    "EVToEBITDA": "290.56",
    "Beta": "None",
    "52WeekHigh": "9.66",
    "52WeekLow": "0.444",
    "50DayMovingAverage": "4.764",
    "200DayMovingAverage": "2.357",
    "SharesOutstanding": "17357900",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "CAPR": {
    "Symbol": "CAPR",
    "AssetType": "Common Stock",
    "Name": "Capricor Therapeutics Inc",
    "Description": "Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.",
    "CIK": "1133869",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA, US",
    "OfficialSite": "https://www.capricor.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "621574000",
    "EBITDA": "-34791176",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "1.693",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.02",
    "RevenuePerShareTTM": "0.732",
    "ProfitMargin": "-1.469",
    "OperatingMarginTTM": "-5.75",
    "ReturnOnAssetsTTM": "-0.347",
    "ReturnOnEquityTTM": "-1.026",
    "RevenueTTM": "23228000",
    "GrossProfitTTM": "-22125772",
    "DilutedEPSTTM": "-1.02",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.634",
    "AnalystTargetPrice": "41.29",
    "AnalystRatingStrongBuy": "3",
    "AnalystRatingBuy": "4",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "26.76",
    "PriceToBookRatio": "10.24",
    "EVToRevenue": "26.5",
    "EVToEBITDA": "-2.734",
    "Beta": "4.112",
    "52WeekHigh": "23.4",
    "52WeekLow": "3.52",
    "50DayMovingAverage": "14.3",
    "200DayMovingAverage": "10.91",
    "SharesOutstanding": "45469900",
    "DividendDate": "2019-06-05",
    "ExDividendDate": "None"
  },
  "RCAT": {
    "Symbol": "RCAT",
    "AssetType": "Common Stock",
    "Name": "Red Cat Holdings Inc",
    "Description": "Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. The company is headquartered in Humacao, Puerto Rico.",
    "CIK": "748268",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "ENERGY & TRANSPORTATION",
    "Industry": "CRUDE PETROLEUM & NATURAL GAS",
    "Address": "7960 E. CAMELBACK, #511, SCOTTSDALE, AZ, US",
    "OfficialSite": "https://redcat.red",
    "FiscalYearEnd": "April",
    "LatestQuarter": "2024-10-31",
    "MarketCapitalization": "476890000",
    "EBITDA": "-22378152",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.346",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.51",
    "RevenuePerShareTTM": "0.235",
    "ProfitMargin": "-2.315",
    "OperatingMarginTTM": "-5.94",
    "ReturnOnAssetsTTM": "-0.295",
    "ReturnOnEquityTTM": "-1.0",
    "RevenueTTM": "16468600",
    "GrossProfitTTM": "1798400",
    "DilutedEPSTTM": "-0.51",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.61",
    "AnalystTargetPrice": "13.5",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "28.96",
    "PriceToBookRatio": "19.64",
    "EVToRevenue": "32.79",
    "EVToEBITDA": "-1.774",
    "Beta": "0.491",
    "52WeekHigh": "15.27",
    "52WeekLow": "0.7",
    "50DayMovingAverage": "9.79",
    "200DayMovingAverage": "4.714",
    "SharesOutstanding": "85618000",
    "DividendDate": "2019-08-01",
    "ExDividendDate": "None"
  },
  "ARBB": {
    "Symbol": "ARBB",
    "AssetType": "Common Stock",
    "Name": "ARB IOT Group Limited Ordinary Shares",
    "Description": "ARB IOT Group Limited, provides Internet of Things (IoT) system solutions, and system integration and support services. The company is headquartered in Kuala Lumpur, Malaysia.",
    "CIK": "1930179",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN",
    "Address": "LEVEL 39, MARINA BAY FINANCIAL, CENTRE TOWER 2, 10 MARINA BOULEVARD, SINGAPORE",
    "OfficialSite": "https://www.arbiotgroup.com",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "13312700",
    "EBITDA": "-35610740",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "9.99",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.46",
    "RevenuePerShareTTM": "2.201",
    "ProfitMargin": "-0.945",
    "OperatingMarginTTM": "-0.125",
    "ReturnOnAssetsTTM": "-0.126",
    "ReturnOnEquityTTM": "-0.188",
    "RevenueTTM": "58187000",
    "GrossProfitTTM": "-20335848",
    "DilutedEPSTTM": "-0.46",
    "QuarterlyEarningsGrowthYOY": "-0.792",
    "QuarterlyRevenueGrowthYOY": "-0.776",
    "AnalystTargetPrice": "3",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.229",
    "PriceToBookRatio": "0.293",
    "EVToRevenue": "1.16",
    "EVToEBITDA": "0.921",
    "Beta": "None",
    "52WeekHigh": "1.65",
    "52WeekLow": "0.215",
    "50DayMovingAverage": "0.494",
    "200DayMovingAverage": "0.486",
    "SharesOutstanding": "26437500",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "BNRG": {
    "Symbol": "BNRG",
    "AssetType": "Common Stock",
    "Name": "Brenmiller Energy Ltd Ordinary Shares",
    "Description": "None",
    "CIK": "1901215",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "HEATING EQUIPMENT, EXCEPT ELECTRIC & WARM AIR FURNACES",
    "Address": "13 AMAL STREET, ROSH HAAYIN, ISRAEL",
    "OfficialSite": "https://www.bren-energy.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2023-12-31",
    "MarketCapitalization": "10928000",
    "EBITDA": "-9477000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "1.097",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-2.24",
    "RevenuePerShareTTM": "0.015",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-233.85",
    "ReturnOnAssetsTTM": "-0.425",
    "ReturnOnEquityTTM": "-1.035",
    "RevenueTTM": "41000",
    "GrossProfitTTM": "-729000",
    "DilutedEPSTTM": "-2.24",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.613",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "266.54",
    "PriceToBookRatio": "1.783",
    "EVToRevenue": "240.38",
    "EVToEBITDA": "-0.906",
    "Beta": "-1.057",
    "52WeekHigh": "3.08",
    "52WeekLow": "0.602",
    "50DayMovingAverage": "1.486",
    "200DayMovingAverage": "1.068",
    "SharesOutstanding": "8094800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "LAES": {
    "Symbol": "LAES",
    "AssetType": "Common Stock",
    "Name": "SEALSQ Corp",
    "Description": "None",
    "CIK": "1951222",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "MANUFACTURING",
    "Industry": "SEMICONDUCTORS & RELATED DEVICES",
    "Address": "AVENUE LOUIS-CASAÏ 58, COINTRIN, CH",
    "OfficialSite": "https://www.sealsq.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "254422000",
    "EBITDA": "-12177420",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.173",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.55",
    "RevenuePerShareTTM": "0.909",
    "ProfitMargin": "-0.653",
    "OperatingMarginTTM": "-1.841",
    "ReturnOnAssetsTTM": "-0.284",
    "ReturnOnEquityTTM": "-5.74",
    "RevenueTTM": "20135000",
    "GrossProfitTTM": "7639000",
    "DilutedEPSTTM": "-0.55",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.673",
    "AnalystTargetPrice": "6",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "12.64",
    "PriceToBookRatio": "46.37",
    "EVToRevenue": "12.07",
    "EVToEBITDA": "-25.85",
    "Beta": "None",
    "52WeekHigh": "11",
    "52WeekLow": "0.29",
    "50DayMovingAverage": "4.376",
    "200DayMovingAverage": "1.591",
    "SharesOutstanding": "104509000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "MRSN": {
    "Symbol": "MRSN",
    "AssetType": "Common Stock",
    "Name": "Mersana Therapeutics Inc",
    "Description": "Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of Antibody Drug Conjugates (ADCs) for cancer patients with unmet needs. The company is headquartered in Cambridge, Massachusetts.",
    "CIK": "1442836",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "840 MEMORIAL DRIVE, CAMBRIDGE, MA, US",
    "OfficialSite": "https://www.mersana.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "59296000",
    "EBITDA": "-77778000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.009",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.6",
    "RevenuePerShareTTM": "0.286",
    "ProfitMargin": "-2.142",
    "OperatingMarginTTM": "-0.958",
    "ReturnOnAssetsTTM": "-0.23",
    "ReturnOnEquityTTM": "-2.803",
    "RevenueTTM": "34837000",
    "GrossProfitTTM": "-37392000",
    "DilutedEPSTTM": "-0.6",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.637",
    "AnalystTargetPrice": "5.33",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "8",
    "AnalystRatingHold": "2",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.702",
    "PriceToBookRatio": "61.64",
    "EVToRevenue": "4.658",
    "EVToEBITDA": "-2.201",
    "Beta": "1.65",
    "52WeekHigh": "6.28",
    "52WeekLow": "0.463",
    "50DayMovingAverage": "0.909",
    "200DayMovingAverage": "1.745",
    "SharesOutstanding": "123533000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "RZLV": {
    "Symbol": "RZLV",
    "AssetType": "Common Stock",
    "Name": "Rezolve AI Limited Ordinary Shares",
    "Description": "None",
    "CIK": "0001920294",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "GENERAL",
    "Address": "NONE",
    "OfficialSite": "https://www.rezolve.com",
    "FiscalYearEnd": "September",
    "LatestQuarter": "0000-00-00",
    "MarketCapitalization": "1730429000",
    "EBITDA": "None",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "None",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.17",
    "RevenuePerShareTTM": "0",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "0",
    "ReturnOnAssetsTTM": "0",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "0",
    "GrossProfitTTM": "0",
    "DilutedEPSTTM": "-0.17",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "2",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "12827.55",
    "PriceToBookRatio": "-",
    "EVToRevenue": "12187.9",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "14.5",
    "52WeekLow": "1.28",
    "50DayMovingAverage": "10.85",
    "200DayMovingAverage": "11.02",
    "SharesOutstanding": "172182000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "SLE": {
    "Symbol": "SLE",
    "AssetType": "Common Stock",
    "Name": "Super League Enterprise Inc.",
    "Description": "None",
    "CIK": "1621672",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-AMUSEMENT & RECREATION SERVICES",
    "Address": "2906 COLORADO AVE, SANTA MONICA, CA, US",
    "OfficialSite": "https://www.superleague.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "5646200",
    "EBITDA": "-14073000",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.3",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-6.92",
    "RevenuePerShareTTM": "3.394",
    "ProfitMargin": "-1.106",
    "OperatingMarginTTM": "-0.795",
    "ReturnOnAssetsTTM": "-0.548",
    "ReturnOnEquityTTM": "-2.446",
    "RevenueTTM": "22266000",
    "GrossProfitTTM": "8828000",
    "DilutedEPSTTM": "-6.92",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.384",
    "AnalystTargetPrice": "2.25",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.254",
    "PriceToBookRatio": "1.962",
    "EVToRevenue": "0.376",
    "EVToEBITDA": "-0.35",
    "Beta": "2.101",
    "52WeekHigh": "2.62",
    "52WeekLow": "0.313",
    "50DayMovingAverage": "0.586",
    "200DayMovingAverage": "0.884",
    "SharesOutstanding": "16904900",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "AGH": {
    "Symbol": "AGH",
    "AssetType": "Common Stock",
    "Name": "Aureus Greenway Holdings Inc. Common Stock",
    "Description": "Aureus Greenway Holdings Inc., owns and operates public golf country clubs in Florida. The company is headquartered in Kissimmee, Florida.",
    "CIK": "2009312",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-MEMBERSHIP SPORTS & RECREATION CLUBS",
    "Address": "2995 REMINGTON BOULEVARD, KISSIMMEE, FL, UNITED STATES",
    "OfficialSite": "https://aureusgreenway.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "43722000",
    "EBITDA": "-65351",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "0.119",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-0.02",
    "RevenuePerShareTTM": "0.298",
    "ProfitMargin": "-0.0829",
    "OperatingMarginTTM": "-0.64",
    "ReturnOnAssetsTTM": "0",
    "ReturnOnEquityTTM": "0",
    "RevenueTTM": "3240800",
    "GrossProfitTTM": "945950",
    "DilutedEPSTTM": "-0.02",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.006",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "13.49",
    "PriceToBookRatio": "33.86",
    "EVToRevenue": "13.67",
    "EVToEBITDA": "-",
    "Beta": "None",
    "52WeekHigh": "7.22",
    "52WeekLow": "0",
    "50DayMovingAverage": "3.5",
    "200DayMovingAverage": "3.5",
    "SharesOutstanding": "13880000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "STBX": {
    "Symbol": "STBX",
    "AssetType": "Common Stock",
    "Name": "Starbox Group Holdings Ltd. Ordinary Shares",
    "Description": "Starbox Group Holdings Ltd. provides digital advertising services to retail business advertisers through websites and mobile applications in Malaysia. The company is headquartered in Kuala Lumpur, Malaysia.",
    "CIK": "1914818",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-ADVERTISING",
    "Address": "VO2-03-07, VELOCITY OFFICE 2, LINGKARAN SV, SUNWAY VELOCITY, KUALA LUMPUR, MY",
    "OfficialSite": "https://www.starboxholdings.com",
    "FiscalYearEnd": "September",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "6808100",
    "EBITDA": "-86407864",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "18.83",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-112.52",
    "RevenuePerShareTTM": "6.1",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-45.08",
    "ReturnOnAssetsTTM": "-0.414",
    "ReturnOnEquityTTM": "-0.903",
    "RevenueTTM": "6174200",
    "GrossProfitTTM": "4076000",
    "DilutedEPSTTM": "-112.52",
    "QuarterlyEarningsGrowthYOY": "-0.771",
    "QuarterlyRevenueGrowthYOY": "-0.778",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.103",
    "PriceToBookRatio": "0.154",
    "EVToRevenue": "2.091",
    "EVToEBITDA": "3.949",
    "Beta": "1.583",
    "52WeekHigh": "5.28",
    "52WeekLow": "0.135",
    "50DayMovingAverage": "8.55",
    "200DayMovingAverage": "19.13",
    "SharesOutstanding": "7457100",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "INTZ": {
    "Symbol": "INTZ",
    "AssetType": "Common Stock",
    "Name": "Intrusion Inc",
    "Description": "Intrusion Inc. develops, markets, and supports entity identification, data mining, cybercrime, and advanced persistent threat detection products in the United States. The company is headquartered in Plano, Texas.",
    "CIK": "736012",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "COMPUTER COMMUNICATIONS EQUIPMENT",
    "Address": "1101 ARAPAHO ROAD, RICHARDSON, TX, US",
    "OfficialSite": "https://www.intrusion.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-12-31",
    "MarketCapitalization": "17019700",
    "EBITDA": "-6798000",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "0.155",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-1.63",
    "RevenuePerShareTTM": "1.094",
    "ProfitMargin": "-1.35",
    "OperatingMarginTTM": "-1.135",
    "ReturnOnAssetsTTM": "-0.595",
    "ReturnOnEquityTTM": "-4.774",
    "RevenueTTM": "5771000",
    "GrossProfitTTM": "4430000",
    "DilutedEPSTTM": "-1.63",
    "QuarterlyEarningsGrowthYOY": "1.25",
    "QuarterlyRevenueGrowthYOY": "0.227",
    "AnalystTargetPrice": "10",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "1",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "2.949",
    "PriceToBookRatio": "6.19",
    "EVToRevenue": "2.894",
    "EVToEBITDA": "-2.615",
    "Beta": "-0.641",
    "52WeekHigh": "7.34",
    "52WeekLow": "0.353",
    "50DayMovingAverage": "1.812",
    "200DayMovingAverage": "1.237",
    "SharesOutstanding": "19342800",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "OPFI": {
    "Symbol": "OPFI",
    "AssetType": "Common Stock",
    "Name": "OppFi Inc",
    "Description": "None",
    "CIK": "1818502",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "FINANCE",
    "Industry": "FINANCE SERVICES",
    "Address": "130 E. RANDOLPH STREET, SUITE 3400, CHICAGO, IL, US",
    "OfficialSite": "https://www.oppfi.com",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "1028500000",
    "EBITDA": "None",
    "PERatio": "32.24",
    "PEGRatio": "None",
    "BookValue": "1.695",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "0.29",
    "RevenuePerShareTTM": "13.5",
    "ProfitMargin": "0.028",
    "OperatingMarginTTM": "0.44",
    "ReturnOnAssetsTTM": "0.118",
    "ReturnOnEquityTTM": "0.35",
    "RevenueTTM": "260661000",
    "GrossProfitTTM": "260661000",
    "DilutedEPSTTM": "0.29",
    "QuarterlyEarningsGrowthYOY": "0.631",
    "QuarterlyRevenueGrowthYOY": "0.256",
    "AnalystTargetPrice": "10",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "1",
    "AnalystRatingHold": "1",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "32.24",
    "ForwardPE": "11.03",
    "PriceToSalesRatioTTM": "3.946",
    "PriceToBookRatio": "5.83",
    "EVToRevenue": "0.952",
    "EVToEBITDA": "7.16",
    "Beta": "1.656",
    "52WeekHigh": "17.73",
    "52WeekLow": "2.253",
    "50DayMovingAverage": "11.02",
    "200DayMovingAverage": "6.25",
    "SharesOutstanding": "110000000",
    "DividendDate": "2024-05-01",
    "ExDividendDate": "2024-04-18"
  },
  "CRML": {
    "Symbol": "CRML",
    "AssetType": "Common Stock",
    "Name": "Critical Metals Corp. Ordinary Shares",
    "Description": "None",
    "CIK": "0001951089",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TECHNOLOGY",
    "Industry": "GENERAL",
    "Address": "NONE",
    "OfficialSite": "https://criticalmetalscorp.com",
    "FiscalYearEnd": "June",
    "LatestQuarter": "2023-12-31",
    "MarketCapitalization": "218019000",
    "EBITDA": "-3219545",
    "PERatio": "None",
    "PEGRatio": "None",
    "BookValue": "-0.236",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-758.79",
    "RevenuePerShareTTM": "0.004",
    "ProfitMargin": "0",
    "OperatingMarginTTM": "-25.42",
    "ReturnOnAssetsTTM": "-0.0428",
    "ReturnOnEquityTTM": "-23.47",
    "RevenueTTM": "117660",
    "GrossProfitTTM": "117660",
    "DilutedEPSTTM": "-758.79",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.058",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1852.95",
    "PriceToBookRatio": "17.5",
    "EVToRevenue": "-",
    "EVToEBITDA": "-",
    "Beta": "0.414",
    "52WeekHigh": "14",
    "52WeekLow": "1.5",
    "50DayMovingAverage": "6.08",
    "200DayMovingAverage": "7.91",
    "SharesOutstanding": "94300000",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "GV": {
    "Symbol": "GV",
    "AssetType": "Common Stock",
    "Name": "Visionary Education Technology Holdings Group Inc.",
    "Description": "Goldfield Corporation provides electrical infrastructure construction services primarily to electrical utilities and industrial customers in the Southeast and Mid-Atlantic regions of the United States and Texas. The company is headquartered in Melbourne, Florida.",
    "CIK": "1892274",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "TRADE & SERVICES",
    "Industry": "SERVICES-EDUCATIONAL SERVICES",
    "Address": "105 MOATFIELD DRIVE, UNIT 1003, TORONTO, ON, CA",
    "OfficialSite": "https://visiongroupca.com",
    "FiscalYearEnd": "March",
    "LatestQuarter": "2024-06-30",
    "MarketCapitalization": "13945900",
    "EBITDA": "114000",
    "PERatio": "11.55",
    "PEGRatio": "None",
    "BookValue": "5.17",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "0.32",
    "RevenuePerShareTTM": "2.905",
    "ProfitMargin": "0.109",
    "OperatingMarginTTM": "-0.0944",
    "ReturnOnAssetsTTM": "-0.0158",
    "ReturnOnEquityTTM": "0.0635",
    "RevenueTTM": "9381000",
    "GrossProfitTTM": "2539800",
    "DilutedEPSTTM": "0.32",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.326",
    "AnalystTargetPrice": "None",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "11.55",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "1.487",
    "PriceToBookRatio": "0.785",
    "EVToRevenue": "8.16",
    "EVToEBITDA": "7.57",
    "Beta": "1.34",
    "52WeekHigh": "8.85",
    "52WeekLow": "1",
    "50DayMovingAverage": "1.799",
    "200DayMovingAverage": "2.261",
    "SharesOutstanding": "3774300",
    "DividendDate": "None",
    "ExDividendDate": "None"
  },
  "WHLR": {
    "Symbol": "WHLR",
    "AssetType": "Common Stock",
    "Name": "Wheeler Real Estate Investment Trust Inc",
    "Description": "None",
    "CIK": "1527541",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "REAL ESTATE & CONSTRUCTION",
    "Industry": "REAL ESTATE INVESTMENT TRUSTS",
    "Address": "RIVERSEDGE NORTH, 2529 VIRGINIA BEACH BLVD., SUITE 200, VIRGINIA BEACH, VA, US",
    "OfficialSite": "https://www.whlr.us",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-09-30",
    "MarketCapitalization": "5830900",
    "EBITDA": "53771000",
    "PERatio": "0.0003",
    "PEGRatio": "0",
    "BookValue": "-173.82",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "26853.76",
    "RevenuePerShareTTM": "503.62",
    "ProfitMargin": "-0.298",
    "OperatingMarginTTM": "0.323",
    "ReturnOnAssetsTTM": "0.0291",
    "ReturnOnEquityTTM": "-0.18",
    "RevenueTTM": "102749000",
    "GrossProfitTTM": "50780000",
    "DilutedEPSTTM": "26853.76",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "-0.017",
    "AnalystTargetPrice": "7",
    "AnalystRatingStrongBuy": "-",
    "AnalystRatingBuy": "-",
    "AnalystRatingHold": "-",
    "AnalystRatingSell": "-",
    "AnalystRatingStrongSell": "-",
    "TrailingPE": "0.0003",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "0.0151",
    "PriceToBookRatio": "-",
    "EVToRevenue": "5.66",
    "EVToEBITDA": "10.64",
    "Beta": "1.583",
    "52WeekHigh": "3801.6",
    "52WeekLow": "1.21",
    "50DayMovingAverage": "22.44",
    "200DayMovingAverage": "307.94",
    "SharesOutstanding": "647160",
    "DividendDate": "2018-04-15",
    "ExDividendDate": "2018-03-28"
  }
}
